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Abstract
Retroviral genomes have been shown to contain regulatory sequences at the
3’ end of their genomes that have been implicated in critical steps of viral life
cycle, including nucleocytoplasmic RNA export, RNA stability, and post nuclear
export functions, such as translation.

Recently mouse mammary tumor virus

(MMTV) has been shown to encode Rem protein and its cis-acting cognate
sequence located at the 3’ of the genome, the Rem-responsive element (RmRE).
Binding of Rem to RmRE facilitates the export of genomic RNA (gRNA) from the
nucleus to the cytoplasm. Using an expression system, our previous results have
shown that unspliced MMTV Gag/Pol RNA could be exported out of the nucleus in
the absence of a functional Rem/RmRE regulatory system, but its translation
required a constitutive transport element (CTE) from Mason-Pfizer monkey virus
that can facilitate its expression. Considering that RmRE is located at the junction
of env/3’ LTR, a region common to all MMTV mRNAs, 3’ RmRE has the potential
to affect all mRNAs. Based on these observations, it was hypothesized that an
additional cis-acting control element, a putative 5’ RmRE, could be present at the
5’ end of the MMTV genome, facilitating gRNA nuclear export by distinguishing
between the unspliced from the spliced mRNAs, whereas the 3’ RmRE on the other
hand, could facilitate translation of all other mRNAs, including the unspliced RNA.

To address this hypothesis, a series of deletion and substitution mutations
were introduced between the major splice donor (mSD) and Gag ATG, a region
that should exclusively be present in the gRNAs. These mutant clones were tested
in transient and stable transfections to determine their effect on gRNA nuclear
export, stability, and translation.

Our results revealed severe defects in the

expression of both unspliced gRNA as well as spliced mRNAs, suggesting that a
cis-acting element could be present at the 5’ end of the MMTV genome modulating
gene expression. Interestingly, nuclear export of the gRNA as well as its stability
was not affected by the mutations. Furthermore, a complete abrogation of Gag and
Env protein expression was observed, suggesting translational defects in the
affected set of mutants. Quantitative real-time PCR analysis revealed that the

ix
mutants were severely compromised in the expression of genomic as well as the
spliced RNAs in the nucleus, suggesting a possible transcriptional defect which
compromised the expression of Gag and Env proteins. We next explored the
possibility of the cis-acting element to serve as a potential transcription factor
binding site. Careful sequence analysis of this region revealed the presence of
mirror repeats that could act as potential recruitment sites for transcription factors.
Preliminary in silico analysis has predicted multiple transcription factors of the zinc
finger family that could interact with this element in a sequence specific manner.
Overall, this study suggests that MMTV contains a cis-acting element at the 5’ end
of the genome which helps regulate gene expression by facilitating transcription of
MMTV mRNAs.

Keywords: Retroviruses, Mouse Mammary Tumor Virus (MMTV), Gene
Expression, Rem, Nucleocytoplasmic export.
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)Title and Abstract (in Arabic

التعبير الجيني لفيروس ال  MMTVيعتمد على التسلسل القصير لتتابعات ال CIS
المتواجدة في منطقة  5’ UTRمن الجينوم الفيروسي
الملخص

لقد اوضحت الدراسات أن الجينومات الفيروسية تحتوي على تسلسل تنظيمي في نهاية
الجينوم ) ( 3’endوالتي تلعب دورا اساسيا في دورة الحياة الفيروسية ،بما في ذلك نقل
الحمض النووي الريبي الى السيتوبالزم ،استقرار الحمض النووي الريبي ،ووظائف ما بعد
النقل من النواة مثل الترجمة .في اآلونة األخيرة ،تبين ان فيروس االورام الثديية )(MMTV
يحتوي على بروتين ال ) (Remوبعض من عناصره كال ) (RmREفي نهاية الجينوم
) ، ( 3’endوقد وجد ان ترابط هذا البروتين مع عنصره ) (RmREيسهل عملية نقل الحمض
النووي الريبي الجيني ( )gRNAمن النواة إلى السيتوبالزم.
باستخدام نظام التعبير الجيني ،أظهرت نتائجنا السابقة أن الحمض النووي الغير مقسم
) (Unsplicedوالذي يحتوي على بروتينات ال  Gag/Envيمكن نقله من النواة في غياب
نظام  ،Rem/RmREولكن ترجمتها تتطلب عنصر النقل التأسيسي ( )CTEمن فيروس
) (MPMVو التي يمكن أن تسهل ترجمتها الى البروتينات الخاصة بها .وبالنظر إلى أن
عنصر ) ( RmREيقع عند تقاطع  ، env/3’ LTRوهي منطقة مشتركة لكل االحماض
النووية لفيروس ال  ، MMTVفأن هذا العنصر لديه القدرة على التأثير على جميع هذه
االحماض .واستنادا إلى هذه المالحظات ،فقد تم وضع فرضية ان هناك عنصر )(5’ RmRE
يمكن ان يتواجد في نهاية الجينوم ) ( 5’endوالذي يسهل عملية نقل الحمض النووي من النواة
عن طريق التمييز بين الحمض النووي المقسم وغير المقسم .على الجانب االخر فان عنصر ال
) (3’ RmREيسهل من عملية ترجمة االحماض النووية بما في ذلك الحمض النووي الغير
المقسم .وللتحقق من هذه الفرضية ،تم إدخال سلسلة من الطفرات على الحمض النووي
الفيروسي ما بين الحذف اواالستبدال في المنطقة ما بين ) (mSDو بداية بروتين ال  Gagوهي
المنطقة التي ينبغي أن تتواجد حصريا في الحمض النووي .وقد تم اختبار هذه الطفرات في
عملية ال  transfectionالعابرة والمستقرة لتحديد تأثيرها على نقل واستقرار وترجمة
الحمض النووي.

xi

كشفت نتائج التجارب لهذه السلسلة من الطفرات عن وجود تأثير سلبي حاد في التعبير
الجيني لكل من الحمض النووي الريبي المقسم وغير المقسم ،مما يشير إلى أن هناك عنصر
اخر مهم متواجد في نهاية الجينوم ) ( 5’endهو المتحكم الرئيسي في هذه العملية .ومن المثير
لالهتمام ،ان عملية نقل واستقرار الحمض النووي الريبي لم تتأثر بهذه الطفرات .وعالوة على
ذلك ،فقد لوحظ إلغاء كامل للتعبير الجيني لبروتينات  ، Gag , Envمما يشير إلى التأثيرات
السلبية لهذه الطفرات على عملية الترجمة الخاصة بهذه البروتينات .وكشف التحليل الكمي لل
 PCRان هذه الطفرات اثرت وبشكل كبير على التعبير الجيني الخاص بالحمض النووي الريبي
المقسم وغير المقسم مما يرجح احتمالية تناقص كبير في عملية النسخ والتي اثرت على تكوين
بروتينات ال .Gag, Env
وقد بحثنا الحقا في امكانية ان يلعب عنصر ال  cisبمثابة عامل النسخ االساسي .وقد
كشف التحليل المتسلسل الدقيق لهذه المنطقة عن وجود تكرار المرآة والتي يمكن أن تكون بمثابة
مواقع التوظيف المحتملة لعوامل النسخ .وتوقع التحليل األولي ) (in silicoعن وجود عدة
عوامل للنسخ من عائلة الزنك والتي يمكن أن تتفاعل مع هذا العنصر بطريقة محددة التسلسل.
وعموما ،تشير هذه الدراسة إلى أن فيروس ) (MMTVيحتوي على عنصر ال ) (cisفي
نهاية الجينوم ) ( 5’endوالذي يساعد على تنظيم التعبير الجيني من خالل تسهيل عمليات نسخ
الحمض النووي الريبي لفيروس ).(MMTV

مفاهيم البحث الرئيسية :الفيروسات االرتجاعية ،فيروس الورم الثديي ) ،(MMTVالتعبير
الجيني ،Rem ،نقل الحمض النووي الريبي.
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Chapter 1: Introduction
1.1 Retroviruses
Retroviruses make up a large and diverse group of single-stranded RNA
viruses infecting a wide variety of vertebrates, ranging from fish to humans (Weiss,
1996). They belong to the Retroviridae family and have been extensively studied due
to their ability to cause neoplastic diseases such as leukemia and lymphomas in
animals (Coffin, 1997). Retroviruses first came into light at the beginning of the
20th century, when it was discovered that an agent later termed as “virus” can cause
leukemia in chicken (Rous, 1911). Since their discovery, significant advancement
has been made in the field of retrovirology (Hayward, 2017).
The size of a typical retrovirus is about 80-100 nm in diameter. The genome
consists of two copies of 7-12 kilobases (kb) long single stranded RNA molecules of
positive polarity which are non-covalently linked as a dimer at their 5’ ends
(Pedersen & Duch, 2001). Retroviruses have an extraordinary and distinctive life
cycle that differentiates them sharply from other viruses. This is due to the presence
of a unique enzyme, reverse transcriptase (RT) that enables these viruses to reverse
transcribe their single-stranded RNA genomes into double-stranded DNA
(Baltimore, 1970; Temin and Mizutani, 1970). This reverse transcribed intermediate
retroviral DNA genome then becomes competent to integrate into host chromosomal
DNA with the help of another viral enzyme, integrase (IN). The integrated provirus
may remain latent and replicate along with the rest of host DNA.
Initially, retroviruses were classified based on ultrastructure morphology of
virion core under an electron microscope as well as virus assembly (Coffin, 1979).

2
According to this system, retroviruses were classified into four types (types A-D)
(Figure 1.1). The most common type, which assemble their nucleocapsid near the
plasma membrane and close to site of budding were termed as C-type. For example,
Avian Leukosis and Sarcoma Viruses (ALSV) that have been shown to contain
centrally-located core and poorly visible spikes. Whereas, the B-type particles
represented by Mouse Mammary Tumor Virus (MMTV) were shown to have
eccentrically arranged cores with prominent spikes. Other non-infectious and nonenveloped retroviruses that have been shown to be cytoplasmic are termed as A-type.
Retroviruses that infect primates were termed as D-type that possesses properties of
both B- and C-type retroviruses such as Mason-Pfizer Monkey Virus (MPMV)
(Coffin, 1979; Verma, 1983; Weiss, 1996).

Figure 1.1: Classification of retroviruses based on ultrastructure morphology
(A) Type A particles (B) Type B. Mouse mammary tumor virus (C) Type C. Murine
leukemia virus (D) Type C. Avian leukosis virus. (E) Type D. Mason-Pfizer monkey
virus. (F) BLV/HTLV. Bovine leukemia virus. (G) Lentivirus. (H) Spumavirus.
Figure taken from Coffin et al., 1997.
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With the advent of modern sequencing technologies, a new system of viral
classification was devised based on multiple sequence alignment and phylogenetic
analysis of the conserved amino acids contained within domains of the reverse
transcriptase gene of retroviruses (Xiong and Eickbush, 1990). The new system
classifies retroviruses into seven groups shown in Table1.1.

Table 1.1: Classification of Retroviruses (adapted from Goff, 2001)
Genus

Symbol

Representatives

Alpharetrovirus

α

Betaretrovirus

β

Gammaretrovirus

γ

Deltaretrovirus

δ

Epsilonretrovirus
Lentivirus

ε
−

Spumavirus

−

Rous Sarcoma Virus (RSV)
Aviam Leukosis Virus (ALV)
Mouse Mammary Tumor Virus (MMTV)
Human Endogenous Retrovirus K (HERV-K)
Mason-Pfizer Monkey Virus (MPMV)
Jaagsiekte Sheep Retrovirus (JSRV)
Murine Leukemia Virus (MLV)
Feline Leukemia Virus (FeLV)
Human T-lymphotropic Virus (HTLV)
Bovine Leukemia Virus (BLV)
Walleye Dermal Sarcoma Virus
Human Immunodeficiency Virus (HIV)
Simian Immunodeficiency Virus (SIV)
Feline Immunodeficiency Virus (FIV)
Human Foamy Virus (HFV)
Simian Foamy Virus (SFV)

1.2 Retroviral Genome Organization
The retroviral RNA genome is a dimer inside the virus particle. The RNA
genome is first converted to a DNA intermediate that is transcribed into the genomic
RNA (gRNA) for completion of the viral replication cycle (Figure 1.2A). A typical
retroviral genome consists of: i) trans-acting coding sequences for the proper
expression of genes, and ii) cis-acting non-coding control sequences that play
important regulatory roles during viral replication (Figure 1.2B; Pedersen & Duch,
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2001). The retroviral RNA genome has a distinctive organization prior to reverse
transcription. It contains unique sequences at both the 5’ (U5) and 3’ (U3) ends of
the RNA genome flanked by a stretch of repeat sequences (R) at either ends (Figure
1.2A). During the course of reverse transcription, the U5 sequences are duplicated at
the 3’ end, whereas the U3 sequences are duplicated at the 5’ end, generating
identical long terminal repeats (LTRs) at both the 5’ and 3’ ends of the virus (Figure
1.2A; Temin, 1981). The U3 region houses the transcriptional control elements of
the provirus, including the promoter and enhancers.

Figure 1.2: Retroviral genome organization
Schematic representation of: (A) the proviral double-stranded DNA integrated into
the host genome (shown as wavy lines) and the RNA genome along with location of
the important cis- and trans-acting factors of the virus. PBS, primer binding site;
PPT, polypurine tract. The blue circle represents the 5’ cap structure on the mRNAs,
while the runs of As depict the polyadenylated 3’ ends. U3/U5, unique 3’ and 5’
sequences; R, repeat region. (B) Comparison of a simple and complex retroviral
genome. MA, matrix; CA, capsid; NC, nucleocapsid; PR, protease; RT, reverse
transcriptase; IN, integrase; SU, surface part of env gene; TM, transmembrane part of
env gene.
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The site for transcription initiation is present at the boundary of U3 and R,
whereas the R and U5 boundary contains the poly (A) sequences. Some other
important non-coding sequences found within the genome include the primer binding
site (PBS) and polypurine rich tract (PPT) required during reverse transcription
(Figure 1.2A; Coffin et al., 1997). The common viral structural genes include group
specific antigen (gag) and envelope (env), whereas enzymatic genes include
polymerase (pol) and protease (pro). The structural gag gene encodes the Gag
polyprotein precursor which undergoes proteolytic processing by the viral protease to
form matrix (MA), capsid (CA) and nucleocapsid (NC) proteins (Figure 1.2B). The
mature CA protein forms the viral capsid that houses the retroviral RNA genome,
MA is present on inner side of the envelope and are associated with viral membrane,
whereas NC plays a major role during encapsidation and/or packaging of unspliced
gRNA (Kuzembayeva et al., 2014). The pol gene encodes for two crucial enzymes,
including RT and IN, that are used during viral replication. The protease enzyme
utilized for the cleavage of Gag-Pro-Pol polyproteins is virally encoded using the pro
open reading frame (ORF) that differs in genomic location according to the virus
type.

The env ORF encodes for Env precursor protein, which is subsequently

cleaved into the surface glycoprotein (SU) and transmembrane (TM) by cellular
proteases (Figure 1.2B). SU is specifically required for interaction with the cellular
receptor proteins during viral attachment to the target cell, whereas TM facilitates
viral fusion with the cell membrane.
Different members of retroviruses have been shown to contain a number of
accessory genes in addition to aforementioned canonical genes. For example, HIV-1
has been shown to contain trans-activator (tat), regulator of virion (rev), virion
infectivity factor (vif), and viral protein r (vpr), and negative regulatory factor (nef)
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genes (Figure 1.2B). In addition to the previously discussed classification systems, a
rather conventional system is also often used based on genome complexity of
retroviruses. According to this classification, retroviruses are divided into “simple”
or “complex” (Figure 1.2B). Simple retroviruses contain only the canonical gag,
pro/pol and env genes, whereas complex retroviruses, in addition, also contain other
accessory genes having regulatory or pathogenic functions (Coffin et al., 1997;
Murphy et al., 1994).
1.3 Retroviral Life Cycle
Retroviral life cycle initiates with virus binding to the host receptor on target
cell membrane using the SU domain of the virally-encoded Env glycoproteins
(Figure 1.3A). The binding is followed by the fusion of viral membrane with the
host cell membrane using its TM domain, and entry of the viral core inside the host
cell cytoplasm. Upon successful entry, the viral RT enzyme reverse transcribes the
single-stranded RNA into a double-stranded DNA genome which is further
processed and associates with viral and cellular proteins, creating the pre-integration
complex (PIC). The PIC enters the nucleus where the viral DNA integrates within
the host cell genome, a hallmark of retroviruses. Following integration, the viral
DNA genome is called a “provirus” which becomes part of the host genetic material
and utilizes the host cellular machinery to transcribe the structural, regulatory, and
accessory genes of the virus (Figure 1.3A). The viral transcripts thus expressed are
exported out of the nucleus by specific transport pathways for translation into various
proteins. The full-length RNA is used for both Gag/Pol protein expression as well as
encapsidation into the newly-synthesizing virions. The virions that are produced bud
from host cell at the plasma membrane, acquiring the cell membrane and Env

Figure 1.3: Key events in retroviral life cycle
(A) Retroviruses use their envelope proteins to latch onto specific receptors on target cell surface. The viral core is internalized after membrane
fusion and viral RNA is released inside the cell cytoplasm. It undergoes reverse transcription to generate a double stranded DNA copy,
competent to pass through nuclear membrane for undergoing integration into host genomic DNA with the help of viral integrase enzyme. (B)
During the second phase of retroviral life cycle, the mRNAs are transcribed and undergo post-transcriptional processing after which they are
transported out of the nucleus to make viral proteins using host cell translational machinery. The spliced mRNAs are used to make Env and viral
accessory proteins, while the unspliced full length mRNA expresses the Gag-Pol proteins. Furthermore, the full-length RNA is used for
encapsidation into the new virions. The Gag protein interacts with dimerized RNA and packages it into new viral particles that are released from
plasma membrane. Figure from Stoye et al., 2012.
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proteins in the process, and marking the successful completion of a retroviral life
cycle (Figure 1.3B). These steps are further discussed in more detail next.
1.3.1 Receptor binding and entry
Retroviruses bind to extracellular surface of its target cell using viral
envelope glycoproteins (gp) through interacting with specific cellular receptors. For
example, HIV-1 utilizes the CD4 receptor on the cell along with chemokine coreceptors, CXCR4 (T-cell tropic) or CCR5 (macrophage tropic) (Maddon et al.,
1986; Feng et al., 1996; Alkhatib et al., 1996). MMTV, on the other hand, uses the
TfR1-containing endosomal compartment for entry into permissive cells (Ross et al.,
2002). Multimerization of these envelope glycoproteins on the cell surface after
interaction with cellular receptor initiates its fusion to the host cell membrane. For
example, in the case of HIV-1, the gp120 monomers (Layne et al. 1990; Moore and
Nara, 1991) or monomers of gp52 of MMTV (Bolander, 1996) oligomerize and
undergo conformational changes prior to fusion and internalization of the viral core
(reviewed in Sommerfelt, 1999). After successful fusion is achieved through
synergistic efforts of SU and TM envelope proteins, the viral core is released inside
the cell (Figure 1.3A). This is followed by one of the most crucial steps of retroviral
life cycle, reverse transcription.
1.3.2 Reverse transcription
The RT enzyme is unique with three distinct properties:

i) an RNA-

dependent DNA polymerase activity, ii) an RNase H activity to cleave the RNADNA duplexes, and iii) a DNA-dependent DNA polymerase activity (Varmus and
Brown,1989).

DNA synthesis begins with the minus strand formation by the
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annealed host tRNA (specific for each retrovirus type) which is bound to its
complementary sequence on the PBS to initiate the process of reverse transcription
(Figure 1.4; reviewed in Coffin and Rosenberg, 1999). A short 100-150 nts minus
strand strong-stop DNA (-sssDNA) is made at the 5’ end of viral RNA. The RNA
and -sssDNA duplex is cleaved by the RNase H activity of RT. The newly formed
short DNA fragment (-sssDNA) is transferred to the 3’ end of the viral RNA due to
the sequence homology between “R” regions at both ends and is often referred as the
“first strand transfer” (Figure 1.4). It is believed that “first strand transfer” and
subsequent annealing of -sssDNA to 3’ end of the viral genomic RNA is mediated by
the NC proteins. In the next step, minus strand DNA synthesis resumes from the 3’
end and continues until it reaches the 5’ end of the RNA genome, resulting in the
formation of an RNA:DNA hybrid (Figure 1.4). The RNA part of this hybrid is
digested by the RNase H activity of the RT enzyme. During this process, the RNAse
H is incapable of digesting PPT, which is resistant to its degradative activity. This
results in the creation of a short primer which in turn starts the plus DNA strand
synthesis. Plus-strand synthesis is halted after a portion of the primer tRNA is
reverse-transcribed, yielding the newly synthesized fragment, named as plus strand
strong stop DNA (+sssDNA) (Figure 1.4). Annealing of the complementary PBS
sequences in +sssDNA and minus-strand DNA carries out the “second strand
transfer” and formation of both strands is completed in opposite directions using
each other as templates. The resulting blunt-ended DNA contains two LTRs each
consisting of the sequence block U3-R-U5 (Swanstrom et al., 1982; Coffin 1997;
Whitcomb and Hughes 1992; Telesnitsky and Goff 1997).
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Figure 1.4: Mechanism of reverse transcription in retroviruses
The process of reverse transcription of gRNA is carried out by virally encoded
reverse transcriptase (RT) enzyme. A tRNA complementary to primer binding site
(PBS) binds and continues synthesis until the 5’ end of template genome. RNase H
activity of RT detaches this newly-synthesized RNA (-sssDNA) from that end. Due
to the presence of complementary “repeat” (R) sequences in –sssDNA, it base pairs
to repeat region (R) at 3’ end of genome and resume its synthesis until RNA from
RNA:DNA hybrid is digested by RNase H, sparing the polypurine tract (PPT)
resistant to its digestion. The left-over fragment at PPT acts as a primer and begins
the synthesis of plus strand of DNA (+sssDNA). After its synthesis, it is removed
from RNA and second strand transfer occurs. Complementary sequences on both
+sssDNA and –sssDNA base pair and synthesis is resumed using each other as
template in opposite directions until both strands are complete and yield a double
stranded DNA. Image acquired from http://www.bioafrica.net/proteomics/POLRTprot.html
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1.3.3 Integration
The blunt-ended DNA duplex, while still in the cytoplasm, is processed by
the virally encoded IN to remove the terminal two phylogenetically-conserved
TG/CA nucleotides, 5’-TG----CA-3’ (reviewed in Desfarges and Ciuffi, 2010). This
integration-competent form of viral DNA in association with viral and cellular
proteins is termed as the pre-integration complex (PIC). The PIC is imported into the
nucleus in different ways depending upon the type of virus. For example, a simple
retrovirus like MLV accomplishes the PIC nuclear import during mitosis, when the
absence of nuclear boundary is used as an advantage. This is one reason why MLV
cannot infect non-dividing cells. In contrast, HIV-1 utilizes the cellular protein
“nuclear import factor for serine/arginine-rich proteins” (TNPO3) that interacts with
HIV-1 CA and other proteins to import the PIC into the nucleus, thus allowing it to
cross into the nucleus in the absence of mitosis (Diaz-Griffero, 2012). This allows
HIV to infect both dividing and non-dividing cells. In the case of MMTV, import of
PIC is independent of TNPO3 even though MMTV has recently been shown to infect
both dividing and non-dividing cells (Konstantoulas & Indik, 2014).
Once in the nucleus, integration of viral DNA occurs, which follows the same
mechanism as transposition (Shapiro, 1979). The recessed 3’ termini OH group
brings about the catalytic reaction in host DNA integration site characterized by the
duplication of 4-6 nts short sequences at both ends flanking the viral sequence (Dhar
et al., 1980; Hughes et al., 1981). The gaps are filled at the junctions by cellular
DNA polymerases following integration, and mismatched viral 5’ end sequences are
trimmed, completing the integration process and resulting in the formation of a
“provirus”.
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For a long time, it was believed that retroviruses integrate randomly into the
host genome. However, it is becoming clearer that they have specific preference for
the regions that they integrate into, such as sites of active transcription, start sites of
genes, or within genes (Desfarges and Ciuffi, 2010; Konstantoulas and Indik, 2014).
For example, gammaretorivurses prefer promoter regions, while lentiviruses prefer
sites along transcriptional units. The site selection is thought to be influenced by
several factors, including accessibility of the chromatin, state of the cell cycle, and
cellular proteins available to help tether the PIC to the site of integration.
1.3.4 Gene expression and post-transcriptional modifications
After successful integration of the reverse transcribed DNA, the
transcriptional machinery of host cell is employed to make the full-length and spliced
RNA molecules for viral protein production (Figure 1.3B). In addition to the viral
promoter in the U3 region, the viral genome contains cis-acting elements spread
within the LTR that work in combination with cellular RNA polymerase II and other
proteins to accomplish this step. For example, HIV-1 employs the virally-encoded
transcriptional activator (Tat), which binds its cognate trans-activating (TAR) RNA
element in the “R” region to facilitate activation and efficient elongation of the
transcripts for enhanced viral gene expression (Dayton et al., 1986; Bannwarth and
Gatignol., 2005). MMTV, on the other hand, contains two promoters within the LTR
and one in the Env region. The LTR promoters are further activated by hormone
responsive elements (HREs) in the U3 region that upregulates MMTV gene
expression upon hormone stimulation (Günzburg and Salmons et al., 1992). After
transcription, a reasonable fraction of these full-length mRNAs undergoes single or
multiple splicing events to generate the subgenomic mRNAs, suitable to code for
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viral proteins (Figure 1.3B). However, in order to maintain the continuity of viral
life cycle, some portion of the full-length RNA is kept unspliced which then serves
as a substrate for Gag-Pol polyproteins during translation and as gRNA to be
encapsidated into the newly-formed virions. Both the spliced and unspliced RNAs
must undergo post-transcriptional modifications to acquire a 5’ end methyl cap and
polyadenylation at the 3’ end (Nakielny and Dreyfuss, 1999) before they are ready to
be exported to the cytoplasm.
1.3.5 Translation
Once the retroviral mRNAs are exported to the cytoplasm, they are translated
into proteins using the host cell translational machinery. The singly spliced Env
mRNAs are translated on ribosomes attached to the rough endoplasmic reticulum
(RER) since Envs are highly glycosylated proteins (reviewed in Balvay et al., 2007).
After a series of post-translational modifications, the Env glycoproteins are cleaved
into SU and TM proteins by cellular proteases during their transport to the surface of
the cell. The unspliced mRNA, on the other hand, is used for making the Gag-ProPol polyproteins on free ribosomes. Either stop codon suppression or ribosomal
frame shifting process is used to ensure proportional production of Gag, Pro and Pol
proteins using the same mRNA (Coffin et al., 1997; Brierley & Dos Ramos, 2006).
Ribosomal frame shifting involves a slippery sequence and a pseudoknot of RNA
secondary structure together called the ribosome frame-shifting signal (RFS). During
ribosomal frameshifting, ribosomes move to a different reading frame and continue
translation in that reading frame. Because only a proportion of ribosomes undergo
frameshifting at each slippery sequence, there is a gradient of translation from the
reading frames at the 5’ end of the mRNA to those at the 3’ end. In complex

14
retroviruses, the full-length mRNA also undergoes multiple splicing events in the
nucleus to give rise to different regulatory and accessory proteins such as Tat, Rev
and Nef, in the case of HIV-1 (Sharp and Marciniak, 1989; Rosen, 1992).
1.3.6 Dimerization and packaging
A second major role of unspliced mRNA in the retroviral life cycle is during
the formation of new virions as it provides the genetic material for newly budding
viral particles.

The gRNA of retroviruses has been shown to contain the

dimerization and packaging sequences at the 5’ end of their genome (Figure 1.5;
Johnson and Telesnitsky, 2010; Ali et al., 2016, Comas-Garcia et al., 2016; Kaddis
and Parent, 2016).

A palindromic (pal) or semi-palindromic sequence creates

structural helix loops which are considered to act as dimerization initiation site (DIS)
(reviewed in Johnson & Telesnitsky, 2010). The pal site helps in base pairing
between the complementary sequences of two gRNAs to initiate the “kissing loop
interaction” that results in the formation of stable gRNA dimer (Figure 1.5; Clever et
al., 1996; Haddrick et al., 1996; Paillart et al. 1996). Nonetheless, DIS varies greatly
among the members of retroviruses. The packaging signal (Ψ), which shares the
same genomic territory as dimerization sequences, is required for the selective
packaging of only full-length RNA into virions. Following the “kissing loop
interactions” during dimerization, the two gRNAs undergo conformational changes
exposing the otherwise hidden NC binding sites on gRNAs for contact with NC
domain of Gag precursor protein (Johnson & Telesnitsky, 2010; Miyazaki et al.,
2011), resulting in more efficient recognition of the dimerized RNA molecules
suitable for packaging. It has been proposed that interactions between NC domain
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and Gag polyprotein can take place either in the cytoplasm or at the plasma
membrane (Figure 1.5; reviewed in Johnson & Telesnitsky, 2010).

Figure 1.5: Retroviral RNA dimerization and packaging
The picture represents the gRNA dimerization and packaging in HIV-1 (A) Two
copies of full-length RNA form dimer by joining at NC site (shown in green) and are
packaged inside the capsid core. (B) Palindromic stem loops initiate dimerization
through kissing loop interaction and successive conformational changes expose
single stranded NC binding motifs (shown in yellow) that is recognized by NC
binding domain of Gag polyprotein. (C) Depending upon the site of association of
dimerization competent RNA, different viruses make homodimer in the nucleus
(shown in red and green) and heterodimer in cytoplasm e.g. in HIV-1. (D) Dimerized
gRNA could be sub-assembled in cytoplasm (top) and then transported to plasma
membrane and it can directly be transported to membrane (bottom) for assembly. (E)
Two copies of RNA dimerized and packaged buds in the form of new viral particles.
Figure adapted from Johnson and Telesnitsky, 2010.
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1.3.7 Assembly and exit
The Gag polyprotein plays a central role in the assembly of retroviral
particles. The process of assembly takes place at different subcellular locations
depending upon the type of retrovirus (reviewed in Bush and Vogt, 2014). In type A
retroviruses, the assembly takes place in the cytoplasm with a stable structure
formation by Gag polyproteins called “intracytoplasmic A-type particle” (ICAP).
These ICAPs are transported to the cell membrane to acquire the Env glycoproteins
during budding. Such a method of assembly is followed by type B (MMTV) and
type D (MPMV) classes. In type C retroviruses, virion assembly is independent of
ICAP formation, and aggregates of polyprotein form directly near the inner side of
the plasma membrane. Once formed, the aggregated viral RNA/polyprotein complex
buds out of the plasma membrane using the normal route (Figure 1.5). These virions
are immature, and activation of the viral protease within the virus particle post
budding initiates the final process of virus maturation (Figure 1.6; Mattei et al.,
2016).
1.4 Mouse Mammary Tumor Virus (MMTV)
MMTV is a medium sized type B virus that belongs to the genus
betaretrovirus in the Retroviridea family.

MMTV was first discovered by its

association with the high prevalence of breast cancer in inbred strains of mice by
Bittner in 1936. He observed that there was an agent which is transmitted from
mother to pups through the mother’s milk and results in the formation of breast
cancer in mice; hence, it was named as the “milk agent” (Bittner, 1936). Additional
studies by other groups observed that not only milk but also transfusion of blood
from high risk mice strains to low risk mice could also result in increased occurrence
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of breast cancer in low risk mice (Woolley et al., 1943). Later on, similar viruses
were also observed in the breast cancer of mice (Porter and Thompson, 1948). Owing
to the discovery of this virus by Bittner, it was initially named as “Bittner Virus” and
later on MMTV.

Now it is a well-established fact that MMTV causes breast

carcinomas in mice.

Figure 1.6: Schematic representation of mouse mammary tumor virus immature and
mature particles
MMTV genome consists of two copies of single stranded RNA wrapped by
structural proteins matrix (MA), capsid (CA) and nucleocapsid (NC) synthesized by
translation of the gag gene. The virus also carries non-structural proteins inside the
core, including enzymes such as reverse transcriptase, integrase and protease. The
outer membrane consists of viral envelope proteins as well as part of host cell
membrane acquired during budding from host. Image adapted from:
http://viralzone.expasy.org/66?outline=all_by_species.
1.5 Structure and Genomic Organization of MMTV
Under the electron microscope, MMTV looks like a spherical enveloped
virion with an approximate size of 100 nm in which the viral core is eccentrically
located (Figures 1.1, 1.6, and 1.7; Briggs et al., 2004).

During the process of

budding from the cell, the virus acquires a portion of the cellular plasma membrane
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in its envelope from the host cell like other retroviruses. MMTV envelope consists of
virally-encoded glycoproteins, transmembrane proteins (TM, gp36) as well as
surface proteins (SU, gp52), which are linked through disulfide bonding (Figure 1.6;
Sarkar and Moore, 1974). The inner side of the envelope contains the viral MA
proteins that are bound to the capsid CA proteins, the major structural protein of the
virus.

The CA protein forms a central icosahedral core, which contains the

dimerized single- stranded positive-sense RNA genome linked with the NC protein.
The mature virus particle carries three enzymes with it: PR, IN and RT. IN and RT
are located within the viral core, whereas the PR is found between the capsid and
envelop (Figure 1.6). It also contains a cellular lysyltRNA, which is localized in the
viral core since it is required for the initiation of reverse transcription (Peters and
Glover, 1980; Briggs et al., 2004).

Figure 1.7: MMTV virions under electron microscope
MMTV virions show the spherical morphology with lipid bilayer decorated with
envelope glycoprotein on its surface. Image adapted from: Briggs et al., 2004
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Figure 1.8: Schematic representation of MMTV genome organization, mRNA
transcripts from the U3 and env promoters and their protein products
The MMTV genome contains structural and enzymatic genes gag, pro, pol, dut, and
env as well as the accessory gene rem flanked by LTRs, while the sag gene is
actually encoded within the U3 region of the LTR. The 5’ LTR contains the classical
promoter and another upstream promoter as well as a third promoter within the env
gene shown by yellow stars, while the 3’ LTR contains sequences for transcript
termination. The bold black lines represent exons, whereas the dotted V-lines show
the splicing events. The Gag, Dut, Pro, and Pol proteins are translated from the full
length mRNAs using the LTR promoters as polyproteins. The Env RNA transcript is
also generated using LTR promoter. Sag RNA transcripts are expressed from both
the LTR as well as the internal env promoter unique to MMTV and code for Sag
using two different spliced transcripts. Rem, on the other hand, is expressed from a
multiply spliced transcript using the Env open reading frame (ORF).
The MMTV genome is 9 kb long and consists of a single-stranded, positive sense
RNA (sss+RNA). The 5’ end of the viral RNA contains a methyloguanosine cap
structure, whereas the 3’ end is polyadenylated (Figure 1.8). The double-stranded
viral DNA synthesized after reverse transcription generates two complete LTRs
containing U3-R-U5. Both LTRs contains a short direct repeat (R) sequence of 15
nts, a 120 nts unique sequence region at the 5’ end (U5) and a 1200 nts region found
internal to the R region at the 3’end (U3) (Figure 1.8). The short length of the
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MMTV R and long length of its U3 region makes MMTV rather unique among
retroviruses, with an entire ORF present within the U3 region (Ross, 2008). Unlike
other retroviruses, MMTV LTRs contains a number of regulatory elements that
control viral gene expression in B and T cells such as negative regulatory elements
(NREs), hormone-response elements (HREs) and a mammary gland enhancer (MGE)
(Mok et al., 1992; Zhu et al., 2004). The genome contains two additional promoters:
one about 500 nts upstream of U3/R region and a second one within the env gene
(Figure 1.8). MMTV was initially classified as a simple retrovirus; however due to
the discovery of the presence of three accessory proteins namely dUTpase (dUT),
superantigen (Sag) and regulator of export of mRNA (Rem), it is now considered as
a complex retrovirus (Figure 1.8; Mertz et al., 2005).
Following integration of the reverse transcribed MMTV genome into the host
genome, the resulting provirus generates at least five different transcripts. A fulllength, unspliced RNA is transcribed from the U3 promoter in the 5’ LTR that serves
as the source of viral genome and is packaged into virions. From this full-length
mRNA three polyprotein precursors Gag (Pr77), Gag-Pro (Pr110), and Gag-Pro-Pol
(Pr160) are translated through a double ribosomal frame shift (Hizi et al., 1987; Jacks
et al., 1987). With the virally encoded protease, Gag is further cleaved into CA
protein (p27), NC protein (p14) and MA protein (p10) (Figure 1.8). The Dut
(dUTPase) and protease proteins are the cleavage products of the Gag-Pro precursor.
The role of Dut is still not well understood in MMTV infection, but may have some
role in replication in non-dividing cells similar to its function in other retroviruses
(Payne and Elder, 2001). Cleavage of the Gag-Pro-Pol precursor Pr160, by the viral
protease yields reverse transcriptase and integrase, both of which play roles in
double-stranded viral DNA production and integration into the host genome
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(reviewed in Ross, 2008). The singly-spliced MMTV Env transcript is generated
from the U3 promoter (Figure 1.8). The envelope protein mediates MMTV entry into
cells through the transferrin receptor 1 (Tfr1) (Ross et al., 2002). The envelope
protein contains two chains that are processed by cellular furin enzymes into
transmembrane (TM, gp36), which is responsible for membrane fusion and surface
units (SU, gp52) that contains the receptor-binding site.
Rem and Sag are two accessory proteins that are encoded from alternatively
spliced mRNAs. The Rem protein (33 kDa) is generated from a doubly-spliced
mRNA in the same reading frame as Env and is a homolog of HIV-1 Rev ( Figure
1.8; Indik et al., 2005, Mertz et al., 2005). It binds to a RNA structural element,
RmRE, present at the 3’ end of the genome and facilitates the export of unspliced
MMTV mRNAs from the nucleus to the cytoplasm. Sag (36 kDa) is a
transmembrane protein with its open reading frame located within the 3’ LTR (Choi
et al., 1991). It is generated through two singly-spliced mRNAs that are transcribed
independently from the U3 promoter in the 5’ LTR and the intragenic Env promoter
(Figure 1.8). Sag protein plays a critical role in viral amplification in B-, T-, and
dendritic cells (DC) in the mice. Furthermore, it is also involved in the spread and
propagation of virus from the gut to the mammary glands (Golovkina et al., 1998;
Ross, 2000).
1.6 Nuclear Export of Viral RNAs
Nucleocytoplasmic export of unspliced and spliced retroviral mRNAs is a
prerequisite for a successful retroviral life cycle, since it allows these mRNAs to
utilize the cellular translation machinery present in the cytoplasm, as well as
assembly into the newly synthesizing virions (Figure 1.3B).

The spliced viral

22
mRNAs are exported to the cytoplasm along with cellular mRNAs through the
nuclear pore complex (NPC) consisting of cellular export proteins. These proteins
control the exit of different types of coding and non-coding RNAs produced by the
eukaryotic cells through the nuclear pore for their translation as well as other
functions (reviewed in Okamura et al., 2015). A major proportion of the cellular
spliced mRNAs are transported using the Tip-associated protein (TAP, also called
NXF1/NXT1) nuclear receptor family after post-transcriptional modifications
(Figure 1.9; Nakielny and Dreyfuss, 1999).

Some cellular RNAs like the 5S

ribosomal RNAs (rRNAs), small nuclear RNAs (snRNAs), and a specific subset of
mRNAs (such as c-fos, cox-2, and type I interferons) use the chromosome region
maintenance 1 protein (CRM1) nuclear receptor pathway for their transport out of
the nucleus, whereas tRNAs and miRNAs utilize the Xpo receptors for their transport
(Figure 1.9). Retroviruses hijack these export pathways for the transport of their
mRNAs and thereby escape the cellular checks that prevent the nuclear exit of
unspliced mRNAs.

Figure 1.9: Schematic representation of different nuclear receptors used by cellular
coding and non-coding RNAs for their export to the cytoplasm
The figure shows the different types of coding and non-coding mRNAs produced in a
eukaryotic cell and the type of nuclear receptor system used by their transport to the
cytoplasm. Figure taken from Okamura et al., 2015.
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Mainly, there are two modes for unspliced and partially spliced mRNAs to
exit the nucleus: i) either take the help of a simple cis-acting RNA elements which
can bind to cellular proteins, or ii) utilize virally-encoded proteins that binds in trans
to viral structural RNA elements to carry out the export function. Specifically,
spliced retroviral mRNAs use the TAP-dependent classical pathway for their
transport. Since unspliced mRNAs are normally not transported to the cytoplasm in
the eukaryotes, efficient escape of unspliced RNA from the nucleus is facilitated by
the presence of cis-acting sequences in their genome that folds into RNA structural
elements. These elements allow them to hide from the cellular proofreading system
for quality gene expression (Cullen et al., 2003; Behm-Ansmant et al., 2007). These
secondary RNA structural elements bind specifically to their cellular or viral cognate
partners either in cis or trans and then recruit other cellular factors for their eventual
export to the cytoplasm details of which are discussed next for different retroviruses.
1.6.1 The Constitutive Transport Element (CTE) of MPMV
The simple retrovirus, MPMV, contains the RNA structural element CTE that
binds to cellular rather than viral factors and facilitates the nuclear export of full
length unspliced mRNA (Bray et al., 1994). It is ~220 nts long and spans the 3’
untranslated region (UTR) of the viral genome, folding into a stable stem with
multiple loops (Figure 1.10A; Ernst et al., 1997). The nuclear export function of CTE
is independent of CRM1 because treatment with leptomycin B, an inhibitor of
CRM1, does not inhibit its function (Kang and Cullen, 1999). Instead, CTE exploits
the TAP/NXF1 pathway, binding to TAP through its RNA binding domain and
recruiting its cofactor NxF1 to perform the nuclear export of unspliced MPMV RNA
through the nuclear pore (Braun et al., 2001; Gruter et al., 1998; Cullen 2003;
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Swanson and Malim, 2006).

Furthermore, it has been shown that CTE can

compensate for the transport functions of HIV-1 and SIV Rev/RRE systems (Bray et
al., 1994; Rizvi et al., 1996). The same has been observed, in the case of MMTV
where MPMV CTE could be used successfully to express its Gag/Pol structural
proteins in the absence of Rem/RmRE (Rizvi et al., 2009). However, rather than
affecting the nucleocytoplasmic transport of the mRNAs, it facilitated their
translation.
1.6.2 The Rev Response Element (RRE) of HIV-1
The virally-encoded Rev protein of HIV-1 binds to its cognate Rev Response
Element (RRE) in unspliced and singly-spliced mRNAs to augment their efficient
nuclear export (Pollard and Malim, 1998). Rev accomplishes this through interacting
with the CRM-dependent pathway (Neville et al., 1997). RRE is a highly structured
and conserved RNA element found within the env gene of HIV-1 at the 3’ end of the
viral genome (Dayton et al., 1992; Heaphy et al., 1990). The entire structured region
of RRE is approximately 350 nts long. However, mutational studies have shown that
about 250 nts are sufficient for its function (Mann et al., 1994). Analysis of the
secondary structure of RRE has shown a highly branched and complex structure
characterized by multiple bulges and stem loops (Figure 1.10B; Kjems et al., 1991;
Rausch and Le Grice, 2015).

The tertiary structure of RRE (and the Rev-RRE

complex) was obtained using 3D predictions from computer models along with EM
studies of assembled Rev-RRE complexes (Daugherty et al., 2010). It consists of a
globular "head" with a long stalk extending from it. For the nuclear export of crucial
intron-containing viral messages, such as the genomic and Env mRNAs, RRE assists
as a precise RNA scaffold that coordinates the assembly of multiple complexes of

Figure 1.10: Predicted secondary structure of MPMV CTE, HIV-1 RRE and MMTV RmRE
(A) The helical RNA structure of MPMV CTE (Ernst et al., 1997). (B) HIV-1 RRE consists of a highly branched and complex structure
consisting of 5 stem loops and bulges (Rausch and Le Grice, 2015). Rev protein binding sites at Stem loop IIB, stem loop II junction and
stem IA are indicated in gray ovals. (C) Structure of MMTV RmRE which was predicted based on RNase mapping and functional studies
(Mertz et al., 2009b). The RmRE has a complex structure comprising of a number of stem loops and is found to have resemblance of
HIV-1 RRE. The cleavage sites of RNase V1, A, and T1 are indicated with yellow, green and blue color respectively.
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Figure 1.11: Schematic representation of HIV-1 Rev Response Element (RRE)dependent viral RNA export
In the early life cycle of a retrovirus, all viral transcripts are fully spliced and are
exported out of the nucleus without the need of any viral factors. A subset of these
spliced transcripts code for the Rev protein. Once formed the Rev protein
translocates to the nucleus and helps export the full length and partially spliced
messages to the cytoplasm. It performs its function by interacting with RRE on the
unspliced and partially spliced viral mRNAs. This complex then interacts with the
cellular nuclear export machinery (Crm1) to circumvent splicing and reach
cytoplasm where they are translated and packaged into new virus particles. Image
adapted from Fernandes et al., 2012.
ribonucleoprotein (RNP). Multiple Rev proteins are shown to bind to the RRE in a
specific and co-operative manner (Figure 1.11). Rev binds to stem loop IIB of RRE
with high affinity (Battiste et al., 1996) and acts as an"anchor point", giving it the
ability to bind to secondary sites, such as stem loop IA. This interaction is further
stabilized by protein-protein interactions with other Rev molecules ( Figures 1.10 &
1.11; Mann et al., 1994; Hoffmann et al., 2012). After assembly of a Rev-RRE
complex, other cellular export factors bind with this complex to take the RNA out of
the nucleus through the human CRM1-RanGTP nuclear export pathway (Figures
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1.10 & 1.11). It has been shown that CRM1 binds to the nuclear export sequence
(NES) present in Rev to circumvent splicing and take the entire Rev-RRE complex
out of the nucleus (Fernandes et al., 2012; Fornerod et al., 1997). As mentioned
earlier, the transport function of HIV-1 and SIV Rev-RRE can be substituted by the
MPMV CTE, which are neither structurally similar to HIV-1 RRE nor similar at the
sequence level (Bray et al., 1994; Rizvi et al., 1996; Pasquinelli et al., 1997;
Blissenbach et al., 2010), suggesting different modes of action of these structural
elements.
1.6.3 The Rem Response Element (RmRE) of MMTV
The near simultaneous discoveries from the Dudley and Günzberg
laboratories have helped solve the puzzle of nucleocytoplasmic export of full-length
MMTV gRNA by showing that the virus encodes a previously unknown gene rem,
regulator of export of mRNA that plays a critical role in this process (Indik et al.,
2005; Mertz et al., 2005). Similar to HIV-1 Rev/RRE, Rem functions by recognizing
its cognate cis-acting RNA element, RmRE, at the 3’ end of the viral genome,
overlapping the env/LTR junction (Figure 1.12; Müllner et al., 2008; Mertz et al.,
2009b) which folds into a complex stem-loop structure (Figure 1.10C; Mertz et al.,
2009b). Mapped to a ~480 nts region, deletion of RmRE or Rem has been shown to
abolish nucleocytoplasmic transport of gRNA and Gag protein expression (Mertz et
al., 2005; Müllner et al., 2008).

Initial studies using computational prediction

approaches showed structural resemblance of RmRE with CTE of MPMV (Figure
1.10A; Müllner et al., 2008). However, RNase mapping data along with structure
predictions revealed that RmRE folds into multiple stem loops and displays singlestranded regions more like the complex structure of HIV-1 RRE (Figure 1.10C;
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Mertz et al., 2009b). Furthermore, experiments using reporter-based assays have
shown that some of the other retroviral regulatory proteins like HIV-1 Rev and
HTLV-1 Rex, but not HERV-K Rec can function with MMTV RmRE structural
element in a cell- and species-specific manner, although the effect was more
pronounced on translation than on export (Mertz et al., 2009a). Rem binds to RmRE
structural element and transports the full length unspliced mRNA outside the nucleus
through CRM1-dependent pathway (Mertz et al., 2005; Indik et al., 2005).

Figure 1.12: Schematic representation of nucleocytoplasmic transport of MMTV
spliced and unspliced mRNAs
MMTV genome encodes for spliced and unspliced mRNA. Spliced mRNAs are
transported out of the nucleus through TAP/NXFI dependent pathway, while
transport of unspliced mRNA is facilitated out of the nucleus by binding of Rem on
RmRE structural element through CRM1-dependent pathway.
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Furthermore, it has been proposed that analogous to HIV-1 Rev, binding of
Rem monomers on its primary binding site on RmRE results in further cooperative
binding of Rem on low affinity sites. The protein oligomerization then helps in
recruitment of cellular factors like CRM1 that assists the whole complex in export to
cytoplasm through the nuclear pore (Figure 1.12). Unlike HIV-1, the MMTV singlyspliced Env mRNA nuclear export is not Leptomycin B-sensitive, and only
marginally affected by the deletion of either Rem or RmRE (Mertz et al., 2005),
suggesting that MMTV Env mRNA nuclear transport is not Rem-dependent. This is
despite the fact that both HIV-1 and MMTV Env mRNAs contain their cognate
transport elements.
1.6.4 Other retroviral RNA elements for transport
Rous Sarcoma Virus (RSV), which belongs to alpha retrovirus, family of
simple retroviruses has been shown to contain a CTE-like element called Direct
Repeats (DR) that map to the 3’ end of the viral genome (Ogert et al., 1996). These
repeats flank the src gene of RSV, indirectly interacting with Tap through Dbp5
binding and perform the transport function of unspliced mRNA without the
involvement of CRM1 pathway (Paca et al., 2000; LeBlanc, 2007).
Another simple retrovirus, MLV, on the other hand, employs cis-acting
elements used for other purposes such as the packaging motif psi and sequences in R
region at the 5’ UTR of full-length RNA for the transport of full-length mRNA
(Smagulova et al., 2005). Furthermore, in MLV, both the unspliced mRNA and the
spliced messages utilize the cellular factors Tap and NXF1/NXT1 for their transport
to the cytoplasm, unlike HIV-1 and other complex retroviruses (Pessel-Vivares et al.,
2014).
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In the case of Human T-cell Leukemia Virus (HTLV), the only retrovirus
known to cause leukemia in humans, a 255 nts long RNA transport element has been
found (Bogerd et al., 1991). The highly structured RNA element named RxRE is
also present in U3/R region of the 3’ end of the retroviral genome (Ahmed et al.,
1990; Toyoshima et al., 1990). The virally-encoded Rex protein, a functional analog
of Rev and Rem, interacts with RxRE structural element and mediates the export of
unspliced viral mRNA through the CRM1-dependent pathway (Nakano and
Watanabe, 2012).
The human endogenous retrovirus K (HERV-K) that closely resembles
MMTV has also been shown to encode a 416-429 nts long Rec-responsive element
(RcRE) that interacts with the virally-encoded Rec protein to carry out the export of
unspliced and partially spliced RNA transcripts (Magin et al., 1999). The RcRE,
located in 3’ untranslated region of viral genome has been shown to form seven
different, but stable, stem-loops and a highly flexible middle region through selective
2’-hydroxyl acylation and primer extension (SHAPE) analysis (Langner et al., 2012).
Rec binds to several loops and junctions in RcRE as a tetramer and its binding is
specific to purine rich motifs (Magin-Lachmann et al., 2001; Langner et al., 2012).
Interestingly, HIV-1 Rev protein has been shown to function with RcRE and enhance
the expression of reporter vector (Yang et al., 1999), but HERV-K Rec cannot
function with RmRE (Mertz et al., 2009a).
Another member of betaretrovirus genus, Jaagsiekte sheep retrovirus (JSRV)
contains a cis-acting RNA element called as Rej response element (RejRE) at 3’ of
the JSRV env gene (Nitta et al., 2009; Carporale et al., 2009). The structural
prediction of RejRE using Mfold shows it to fold into several stable secondary stem-
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loops and mutational analysis has revealed that both primary sequence and secondary
structure are functionally important. In contrast to HIV-1 and MMTV, binding of
Rej protein with RejRE is mainly required for translation of unspliced mRNA rather
than its nucleocytoplasmic export and its function is cell line specific (Hofacre et al.,
2009; Nitta et al., 2009).
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1.7 Study Rationale
As has been discussed earlier, MMTV encodes the Rem protein along with its
cognate cis-acting binding element, the RmRE, located at the 3’ end of the viral
genome. Binding of Rem to RmRE facilitates the export of gRNA from the nucleus
to the cytoplasm (Mertz et al., 2005). Previously, in our attempt to express MMTV
Gag/Pol proteins from an expression construct, the MPMV CTE was cloned to
obviate the need of MMTV Rem/RmRE regulatory pathway (Rizvi et al., 2009).
This resulted in efficient expression of MMTV Gag/Pol proteins. Interestingly, the
absence or presence of CTE in our system did not affect nuclear export of MMTV
Gag/Pol mRNA. On the other hand, constructs lacking CTE could not express
Gag/Pol proteins or produce viral particles (Rizvi et al., 2009). Inclusion of CTE in
these MMTV Gag/Pol constructs restored the translation of the Gag/Pol proteins.
This observation suggested that MMTV Gag/Pol expression construct contained a
cis-acting element required for the nuclear export of MMTV gRNA but lacked an
element to facilitate its translation that could be compensated by the MPMV CTE. In
a complex retrovirus such as HIV-1, an additional 5’ Rev responsive element (5’
RRE) has been postulated which binds to Rev protein (Gallego et al., 2003;
Greatorex et al., 2006). Based on these observations, it has been hypothesized that
MMTV may have two RmREs: a 5’ RmRE present at the proximal end of the
unspliced genomic RNA only, responsible for transport of full-length RNA and a
3’RmRE present in all MMTV mRNAs, responsible for their translation (Mertz et
al., 2005 and 2009a). This hypothesis is further substantiated by the findings of
Günzburg & colleagues, who have observed that an element within the 5’ UTR of
MMTV enhances Env gene expression (Hohenadl et al., 2012).
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To address this hypothesis, we investigated the 5’ end of the MMTV genome
to map this putative cis-acting element (5’ RmRE) with the potential to affect
MMTV gene expression by modulating nuclear export of viral RNAs. Specifically,
we introduced a series of mutations in a small area between the major splice donor
(mSD) and beginning of Gag (ATG), a region present only in the full-length
unspliced gRNA, to determine its effect on:


Nuclear export of MMTV genomic and spliced mRNAs



Translation of Gag/Pol and Env mRNAs



Stability of MMTV gRNA



Responsiveness of the putative 5’ cis-acting element to Rem
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Chapter 2: Materials and Methods
2.1 Construction of Expression Vectors
2.1.1 MMTV full-length genomic clones with CMV promoter (SQ5-15)
To address our hypothesis, a series of deletion and substitution mutations
were introduced in a small 24 bps region between mSD and Gag start codon found
exclusively in the gRNA (Figure 2.1). The mutations were introduced in the context
of the full-length genome of MMTV, HYB MTV (Shakelford and Varmus, 1988),
using splice overlap extension (SOE) PCR (Gibbs et al., 1994). In this strategy, two
independent PCRs are conducted using two sets of primers, only one of which
contain the mutation in each set. These PCRs result in the creation of overlapping
DNA fragments containing the mutation in the region of the overlap.

Finally,

another PCR is conducted by using the two annealed PCR products as the template
along with the outer primers, resulting in the generation of a final product containing
the desired mutation at the center of the amplified product. These inserts containing
the mutations were then cloned through a series of steps and the final clones were
named SA5-SA14 (Figure 2.1). These mutant clones along with the wild type (WT)
were then tested in stable transfections of Jurkat cells.
To enhance the expression of MMTV genes in human cells without the need
of hormonal induction, the U3 sequences in the 5’ LTR in these clones (SA5-SA14)
were substituted with human cytomegalovirus (hCMV) promoter. This was
accomplished by replacing the U3 region of the individual constructs with hCMV
promoter in the molecular clone HYB MTV (Shakelford et al., 1988), as has been
described previously (Rizvi et al., 2009). Towards this end, a ~891 nt fragment
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containing hCMV promoter sequence along with ‘R’ and ‘U5’ sequences of MMTV
was removed from DA018 (Rizvi et al., 2009) transfer vector using SalI and BstEII
restriction endonucleases and replaced with a 1276 nts long fragment in the wild type
as well as in the mutant clones mentioned above to obtain the wild type (SQ15) and
mutant clones (SQ5-SQ14), respectively.

Figure 2.1: Mutations introduced into the 5’ end of the MMTV genome
The SA series of clones represent the MMTV genomic clones with the complete
LTR at the 5’ end. The SQ series of clones in the second column represent the
genomic clones with the hybrid CMV/RU5 LTR.
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2.1.2 MMTV 5’ UTR dual LUC clones (SQ16-21)
To determine the Rem-responsiveness of the 5’ cis-acting sequence, another
series of luciferase reporter-based constructs were created that contained the cisacting wild type or mutated region downstream of the luciferase reporter (Figure
2.2). The rationale was that if the cis-acting element was indeed Rem-responsive, it
should bind to Rem and rescue the splicing of the luciferase RNA, allowing
successful expression of the luciferase gene. The plasmids were constructed using
pHMΔeLTRluc (a kind gift from Prof. Jaquelin P Dudley, The University of Texas at
Austin, USA) as the backbone (Mertz et al., 2005). The wild type (SQ15) and mutant
sequences (SQ5, SQ6, SQ10, SQ11) from R to 35 nts of gag (~341 nt) were
commercially synthesized using Integrated DNA Technologies (IDT) G-block
service, and cloned into a ScaI restriction site in pHMΔeLTRluc. The ScaI site was
artificially engineered downstream of the splice acceptor and upstream of simian
virus 40 (SV40) poly (A) signal for the ease of cloning (Figure 2.2). Table 2.1
describes the G-blocks which were inserted to attain the final constructs.

Figure 2.2: Schematic representation of the Rem-responsive clones
PCR-amplified fragments containing either the wild type or mutant regions from
genomic clones SQ5 and 6 were cloned into an artificially-introduced Sca I site in
pHMΔeLTRluc (Mertz et al., 2005).
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Table 2.1: Summary of subgenomic vectors constructed
Vector Description of G-Blocks
Name
SQ16 nt 1179-1419 and
then nt 1478-1520 of
HYBMTV with ScaI site
at 5’ and 3’ end
SQ17 nt 1179-1520 of
HYBMTV with ScaI site
at 5’ and 3’ end
SQ18 nt 1179-1460 and then nt
1485-1520 of HYBMTV
with ScaI at 5’ and 3’ end
SQ19 nt 1179-1460 and then nt
1473-1520 of HYBMTV
with ScaI at 5’ and 3’ end
SQ20 nt 1179-1460 and then nt
1485-1520 of HYBMTV
with ScaI at 5’ and 3’ end
SQ21

nt 1179-1460 and then nt
1473-1520 of HYBMTV
with ScaI at 5’ and 3’ end

Mutation
Construct Description
Introduced
nt 1419-1477 R-U5-UTR-gag 35 bp except
(Δ58 bp-SL4) SL4 of HYB MTV inserted in
ScaI site in pHMΔeLTRluc
Wild type
sequence
nt 1461-1484
(Δ24 bp-5’UTR)
nt 1461-1472
(Δ12 bp-5’UTR)
nt 1461-1484
(substitution
of 24 bp-5’UTR)
nt 1461-1472
(substitution
of 12 bp-5’UTR)

R-U5-UTR-gag 35 bp of HYB
MTV inserted in ScaI site in
pHMΔeLTRluc
R-U5-UTR-gag 35 bp from
SQ5 deletion mutant inserted
in ScaI site in pHMΔeLTRluc
R-U5-UTR-gag 35 bp from
SQ6 deletion mutant inserted
in ScaI site in pHMΔeLTRluc
R-U5-UTR-gag 35 bp from
SQ10 substitution mutant
inserted in ScaI site in
pHMΔeLTRluc
R-U5-UTR-gag 35 bp from
SQ11 substitution mutant
inserted in ScaI site in
pHMΔeLTRluc

2.1.3 MMTV 5’ UTR Kozak clones (SQ22-32)
The region upstream of the Gag ATG that was mutated in our first set of
clones (SA5-SA14) by default contained the Kozak sequences of the gag ORF. To
ensure that any effect of the introduced mutations was not due to inadvertent effects
on the Kozak sequences, another series of reporter-based constructs were generated
to determine the effect of the introduced mutations on the efficiency of the Kozak
sequences (Figure 2.3).

These plasmids were constructed using pGL3-Control

(pGL3C) expression vector (Promega, USA). A 1098 nts fragment containing the
start of the hCMV promoter up to the Gag ATG of MMTV was amplified
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individually from SQ5-SQ15 using Phusion high fidelity polymerase kit (New
England Biolabs, USA). The forward primer (OFM222) complementary to the start
of hCMV promoter was common to all clones, while individual reverse primers
(OFM223-OFM233) specific to wild type or mutant templates (SQ5- SQ15) were
used for the amplifications (Table 2.2).

Figure 2.3: Schematic representation of the Kozak reporter clones
PCR-amplified fragments containing either the wild type or mutant regions from
genomic clones SQ5-15 were cloned into pGL3C luciferase vector from Promega.

The amplified product (hCMV promoter-nts 1179-1485 of HYBMTV) from
the wild type construct (SQ15) was digested with XhoI (site introduced during PCR
in the forward primer) and NcoI (an internal site present in the hCMV promoter) to
create the hCMV (~580 nts) fragment common to all the clones. This fragment was
ligated to pGL3C backbone using complimentary staggered ends. Sequence of
resulting subclone (SQ2) was confirmed by sequencing (Macrogen, South Korea).
Once confirmed, using SQ2 subclone as the backbone, the Phusion polymerase
amplified PCR fragments were each digested with NcoI to generate the other half of
the insert (~518 nts long; including hCMV promoter and MMTV R-U5 up to Gag
ATG) containing different mutations and inserted into the NcoI site of SQ2 to obtain
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the final wild type (SQ22) and mutant constructs (SQ23-SQ32).

This strategy

allowed us to fuse the ATG of Gag to the luciferase gene in the pGL3-C vector.
Table 2.2: List of primers and their description used for this study
Primer
Name
OFM24
OFM25
OFM 26

Primer SequenceDirection
CATGTTTGTGATGGGT
GTGAACCA- Forward
GTTGCTGTAGCCGTAT
TCATTGTC- Reverse
TTTTTTTTTTTTTTTTT

OFM112

CAT CAC AAG AGC
GGA ACG GAC- Forward

OFM113

CCT CTA AAT CAT
CCC AAT CCT- Reverse

OFM114

TCT ACC TAT TGG ATT
GGT CTT ATT GGReverse
ATC GCC TTT AAG
AAG GAC GCC TTC TForward
CCCCTCGAGGTCGACT
CTCAGTACAATCTGCForward
CGGCCATGGTTCCAAT
GGCTCACCGTAACReverse
CGGCCATGGCTCTTCT
CCGTAGGCGGGACReverse
CGGCCATGGTTCCAAT
GGCTCCTCTTCTCReverse
CGGCCATGGACCGTA
ACCTACCTCTTCTCReverse
CGGCCATGGTTCCAAT
GGCTCACCGTACTReverse

OFM115

OFM 222

OFM 223

OFM 224

OFM 225

OFM 226

OFM 227

Target

Purpose/ Reference

GAPDH gene,
multiple species
GAPDH gene,
multiple species
All
polyadenylated
mRNAs
MMTV 5’ UTR
upstream of
mSD
Gag

Mustafa et al., 2003

MMTV 3’ U3

MMTV Env

Mustafa et al., 2003
cDNA synthesis

Mertz et al., 2005
C3H230 (nt 1401-1419)
Mertz et al., 2005
GAG620 (nt 21272107)
Mertz et al., 2005
LTR408 (nt 8964-8938)

5' UTR SQ5
deletion mutant

Mertz et al., 2005
ENV7255 (nt 72317256)
XhoI-SalI pCDNA3 (nt
31-53) KOZAK
constructs
NcoI site (nt 14611481) KOZAK
constructs
NcoI site-KOZAK
construct SQ23

5' UTR SQ6
deletion mutant

NcoI site-KOZAK
construct SQ24

5' UTR SQ7
deletion mutant

NcoI site- KOZAK
construct SQ25

5' UTR SQ8
deletion mutant

NcoI site- KOZAK
construct SQ26

Upstream of
CMV promotor
HYBMTV 5'
UTR
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Table 2.2: List of primers and their description used for this study (continued)
Primer
Name
OFM 228

OFM 229

OFM 230

OFM 231

OFM 232

OFM 233

OFM 329

OFM 330

OFM 331

OFM 332

OTR 580

Primer SequenceDirection
CGGCCATGGTTCCAAT
GGACCTACCTCTTReverse
CGGCCATGGAGATCT
GTTAACGCTAGCGTReverse
CGGCCATGGTTCCAAT
GGCTCGCTAGCGTReverse
CGGCCATGGGCTAGC
GTTAACACCGTAACReverse
CGGCCATGGTTCCAAT
GGCTCACCGTAGTReverse
CGGCCATGGTTCCAAT
GGGTTGTTAACACReverse
GTA CTA ACA TAC
GCT CTC CAT CForward
CAA TTG TTC CAG
GAA CCA GG- Reverse
CCGATACGAGATAGT
ACTCACCCCGTGGCA
ACA- Forward
GCACCACGGTTTAGTA
CTAAAGAGTTTCTGCC
CTT- Reverse
TGA GCT GCG TGT
GGC TCC- Forward

OTR 581

GGC ATG GGG GAG
GGC ATA CC- Reverse

OTR 582

CCA GTG GCT TCC
CCA GTG- Forward

OTR 671

GTC CTA ATA TTC
ACG TCT CGT GTGForward

Target

Purpose/ Reference

5' UTR SQ9
deletion mutant

NcoI site- KOZAK
construct SQ27

5' UTR SQ10
substitution
mutant s
5' UTR SQ11
substitution
mutant sequence
5' UTR SQ12
substitution
mutant sequence
5' UTR SQ13
substitution
mutant sequence
5' UTR SQ14
substitution
mutant sequence
pGL3C plasmid
(Promega)

NcoI site-KOZAK
construct SQ28

pGL3C plasmid
(Promega)
HYBMTV ‘R’
sequence
HYBMTV
within 30 bp of
gag
Actin S. Spliced
mRNA
Actin A. Spliced
or unspliced
mRNA
Actin S-1.
Unspliced
mRNA
MMTV R

NcoI site-KOZAK
construct SQ29
NcoI site-KOZAK
construct SQ30
NcoI site-KOZAK
construct SQ31
NcoI site- KOZAK
construct SQ32
Sequencing KOZAK
clones (nt 5152-5174
pGL3C)
Sequencing KOZAK
clones (nt 381-400
pGL3C)
Rem responsive Gblocks amplification (nt
1173-1178)
Rem responsive Gblock amplification (nt
1503-1520)
Tan et al., 1995
247 bp product w/OTR
581.
Tan et al., 1995
247 bp product w/OTR
580.
Tan et al., 1995
203 bp product w/OTR
581.
nt 1179-1202 of
MMTV R
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Table 2.2: List of primers and their description used for this study (continued)
Primer
Name
OTR 672

OTR 930

OTR 552

Primer SequenceDirection
CTG TTC GGG CGC
CAG CTG CCG CAGReverse
GCT TGT GTG TTG
GAG GTC GCT GAGForward
CGA CTA GTG ATA
TCG TTC CCC TGG TCC
CAT AAG- Reverse

Target

Purpose/ Reference

MMTV PBS

nt 1321-1298 of
MMTV PBS

Primer for
sequencing
CMV promoter
Last 400 bp of
MMTV gag

(nt 90-113 pcDNA3)

Spe I (nt 1885-1867
HYB MTV gag)

2.2 Large Scale Preparation of Plasmid DNAs
Large-scale preparations of plasmid DNAs were performed by the Qiagen
Maxi columns that use the alkaline lysis method (Sambrook Manual). A single
colony of transformed Escherichia coli DH5α was picked for setting the preinoculum in 10 or 25 ml of Luria Bertani (LB) broth (HiMEDIA, India). LB Media
was supplemented with appropriate antibiotics (Ampicillin or Kanamycin) (Sigma,
USA) at a working concentration of 50 μg/ml and cultures were subjected to
overnight shaking at 37 °C incubator. For high copy number plasmids, a 10 ml of
overnight culture was added to 100 ml of fresh LB Media with antibiotics in a 500
ml capacity Erlenmeyer flasks and grown overnight at 37 °C with shaking. For low
copy number plasmids, a 25 ml of pre-inoculum was added to 500 ml freshly
prepared autoclaved LB media with appropriate antibiotics.
The cultures were grown at 37 °C with shaking in a 2-liter flask until the OD
at A600 value of 0.9-1.2 was reached. Next, the plasmid amplification was attained
by the addition of chloramphenicol (Sigma; 34 mg/ml prepared in ethanol to a
working concentration of 170 μg/ml). The cultures were grown for another 16 hours
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with shaking until ready to be processed for plasmid isolation. The bacterial cell
pellets were harvested the next day by centrifugation (Avanti J-26 XPI centrifuge,
Beckman coulter) at 6000 rpm (JA10 rotor, Beckman Coulter USA) for 10 minutes
at 4 °C. The pellets were resuspended in suggested volumes of Qiagen P1 Buffer (50
mM Tris-Cl pH 8.0, 10 mM EDTA, 100 μg/ml RNase A) on ice. For lysis, the
suspension was transferred to 50 ml tubes, and suggested volume of P2 Buffer
(200mM NaOH, 1% SDS w/v) was added, mixed thoroughly by inverting tubes to
ensure efficient lysis, and incubated at room temperature for 5 minutes.
Neutralization was achieved by the addition of P3 Buffer (3.0 M potassium acetate,
pH 5.5) by inverting the tube several times, then incubating on ice for 20 minutes.
The precipitated lysate was spun by centrifugation (rotor JA25.50, Beckman Coulter)
at 9000 rpm for 40 minutes at 4 °C to remove the protein debris.
Meanwhile, Qiagen-tips 500 were equilibrated by adding appropriate volume
of QBT Buffer and allowed to run by gravity flow. The cleared lysates were poured
carefully on the equilibrated columns while leaving the cellular debris at the bottom
of the tubes. The mixtures were allowed to flow by gravity so that the plasmid DNAs
could bind the column. After washing the tips twice with QC buffer, the column
bound plasmid DNAs were eluted using QF Buffer. Next, plasmid DNAs were
concentrated by adding 0.7X volume room temperature isopropanol (Sigma), and
after proper mixing were centrifuged (Allerga X15R centrifuge, Beckman Coulter) at
3,500 rpm for 30 minutes at 4 °C. The precipitated DNA pellets were washed once
with 5 ml, 70% ethanol (Sigma), spun as before, and air dried. Finally, the dried
plasmid DNA pellets were resuspended in 400 µl of Tris-EDTA buffer, pH 8.0 and
the quality of plasmid DNA was determined by measuring its absorbance at 260 and
280 nm wavelength using NanoDrop 2000C Spectrophotometer (Thermo Scientific).
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The plasmid DNAs were stored at 4 °C for short-term or -20 °C for long-term
storage.
2.3 Cell Lines
The human embryonic kidney (HEK) 293T cells were maintained in
Dulbecco’s Modified Eagle’s Medium (DMEM) (Hyclone, USA) supplemented with
10% heat inactivated (1 hour at 55 °C) fetal bovine serum (FBS) (Hyclone), 1%
penicillin and streptomycin (Life Technologies, USA), and 0.1% gentamycin (50
mg/ml w/v solution) (Life Technologies). Jurkat human T lymphoma cells were
grown in Roswell Park Memorial Institute (RPMI) 1640 medium (Hyclone),
supplemented with 10% FBS, 1% penicillin and streptomycin mixture, and 0.1%
gentamycin sulfate.

XC rat fibroblast cells were maintained in DMEM media

supplemented with 10% FBS, 1% penicillin-streptomycin mixture and 0.1%
gentamycin. HC11 normal mouse mammary epithelial cells were cultivated in RPMI
1640 medium supplemented with 10% FBS, 1% penicillin-streptomycin, 0.1%
gentamycin and 0.5 μg/ml insulin (Sigma). All cell lines were maintained in a waterjacketed incubator (Forma series II, Thermo Scientific) set at 37 °C and 5% CO2
level with humidity.
2.4 Transfection Assays
The cell lines mentioned above were transfected using an appropriate method
of transfection for each cell line described below.
2.4.1 Transient transfection using Calcium Phosphate (CaPO4)
The HEK 293T cells were transiently transfected using the CaPO4
precipitation kit (Invitrogen, USA). Briefly, cells were plated 16-20 hours prior to
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transfection at a density of 5 x 105 cells per well in a 6-well plate in a 3 ml volume of
complete media. The test plasmid DNA (6 μg/well) and reporter plasmid DNA
(pGL3C, 250 ng/well) were combined in a 1.7 ml microcentrifuge tube and the final
volume was adjusted to 60 μl with water. Then DNA cocktail buffer (525 μl/6 wells)
was prepared by adding nuclease-free water (67 μl/well), 2M CaCl2 (10.5 μl/well)
and premixed DNAs (60 μl/well). The DNA cocktail mixture was added dropwise to
a snap cap tube (4 ml) containing 525 μl of 2X HEPES-buffered saline (HBS) while
bubbling the mixture. The mixture was vortexed briefly and incubated at room
temperature for 30 minutes.

After incubation, the mixture was added to cells

dropwise in each well while shaking.

After approximately 24 hours post

transfection, cells were washed with phosphate buffer saline (1X PBS) (Hyclone,
USA) to remove DNA precipitates and fresh media was added. The transfected cells
were harvested 72 hours post transfection for isolation of RNA and proteins.
2.4.2 Electroporation for making stable cell lines
Jurkat T cells were stably transfected by electroporation using Gene Pulser II
Electroporator (BioRad, USA). The cells were cultured at 5 x 105 cells/ml of growth
media approximately 24 hours before transfection. On the day of the transfection,
cells were counted and after low speed spin, resuspended at 1.2 x 107 cells per 500 μl
of serum-free RPMI medium. The DNA mixture was prepared using 40 μg of test
plasmid (SA5-SA14 and WT) and 250 ng of reporter plasmid (pGL3C) in a 1.7 ml
microcentrifuge tube. Four hundred microliters of cell suspension was added to the
above tubes and mixed gently on ice. The mixture was then added to 0.4 cm
electroporation cuvettes (BioRad) in a sterile manner and electroporated at 260 V,
950 μF and R10 (720 Ω). The electroporated cells were incubated on ice for 5-10
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minutes and then replated in T-25 flasks (NUNC) in 5 ml of complete RPMI media
containing 20% FBS. After 2-3 days, the stably-expressing cells were selected with
media containing 0.8 mg/ml of hygromycin antibiotic for 2-3 weeks. Periodically,
dead cells were removed by slow speed centrifugation till the stable cell culture
survived.
2.4.3 Transient transfection using Fugene reagent
Transient transfection of HC11 cells was performed using Fugene HD
transfection reagent (Promega, Madison, WI). A day before transfection, 2 x 105
cells/well were seeded in a 6-well plate in 3 ml complete growth media without
antibiotics. For transfection of each well, DNA cocktails were prepared by mixing
2.75 μg test plasmid and 250 ng of reporter plasmid (pGL3C) with 155 μl of
deionized water in 1.7 ml centrifugal tubes. Next, 9 μl of Fugene HD reagent (3:1
ratio with plasmid DNA) was added and mixed thoroughly by pipetting, then
incubated at room temperature for 15 minutes. After incubation, the mixture was
added dropwise to the cells and plates were returned to the incubator. The cells were
harvested 48 hours post transfection.
2.5 Cell Harvesting
Transiently transfected cells were harvested 48 hours post transfection for
further analysis. Supernatants were taken off to remove any dead cells and 1 ml of
DMEM media with 1 ml of ice cold 1X PBS was added to each well. Cells were
taken off the plate surface by gentle pipetting on ice, washed with 5 ml of cold 1X
PBS and resuspended in 1 ml of cold 1X PBS. The cell pellets thus obtained from
one 6-well plate was split into various fractions for DNA, RNA and proteins
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extractions. Briefly, 100 μl (1/10th) of the cell suspension was used for dual
luciferase assay (Promega, Madison, WI). Cells were lysed in 1X Passive Lysis
Buffer (Promega) using at least three freeze/thaw cycles, alternating between dry ice
and 37 oC waterbath. Following the thermal lysis, cells were spun in a bench top
microcentrifuge (Eppendorf Centrifuge 5424R) at 13000 rpm for 5 minutes at 4 oC to
remove the cellular debris. Clear supernatants were transferred to fresh tubes for the
luciferase assay (see below) as suggested by the manufacturer. The protein content of
the cell lysates was estimated by the BioRad protein quantification dye kit using
bovine serum albumin (BSA) as standards.
2.6 Reporter Gene Assays
Either single or dual luciferase assays were used in this thesis.
2.6.1 Firefly luciferase assay
The quantification of firefly luciferase activity in cell lysates was performed
using the Luciferase Assay Reagent II (LAR II) (Promega). For every 2 μl of lysate,
25 μl of LAR II substrate was added, mixed and the luciferase activity measured by
using the Glomax 20/20 Luminometer (Promega) that was set to 5 second delay and
20 second integration time. The values obtained were normalized to the amount of
protein used and transfection efficiency was expressed as a function of luciferase
activity/μg protein.
2.6.2 Dual luciferase assay
The dual luciferase reporter assay (Promega) was used in some experiments
for Rem-responsive clones (SQ16-SQ21). To keep the ratio same for lysates to
substrate for Firefly and Renilla luciferase activites, 4 μl of cell lysate was mixed

47
with 25 μl of LAR II substrate first and reading was taken in the luminometer using
Promega DualGlo program pre-set at 0 delay and 10 seconds integration time. Then
25 μl of Stop & Glo Reagent (Promega) was added to determine the Renilla
luciferase activity. Both readings were obtained in relative light units and normalized
to the protein amounts obtained from Bradford protein quantification assay.
2.7 Subcellular Fractionation of Transfected Cells
Subcellular fractionation was performed to separate the nuclear fraction from
cellular cytoplasmic fractions. Towards this end, 2/3rd of cells from a 6-well plate
were taken and immediately spun at low speed in microcentrifuge (Eppendorf
Centrifuge 5424R) at 2400 rpm for 2 minutes at 4 oC to pellet the cells. The resulting
pellets were gently lysed in 800 μl of DEPC-treated RLN buffer (50 mM Tris pH 8.0,
140 mM NaCl, 1.5 mM MgCl2) along with 0.5% NP40. After 2 minutes on ice, the
lysed cells were gently spun again at 2400 rpm for 2 minutes at 4 oC. Carefully 700
μl of the supernatant (cytoplasmic fraction) was transferred to fresh microcentrifuge
tubes, while the pellet (nuclear fraction) was rinsed with 1 ml of fresh RLN buffer
and lysed in 1 ml TRIzol reagent (Invitrogen). The cytoplasmic fraction was spun
again at 5000 rpm for 5 minutes at 4 oC to remove residual nuclear fraction, if any.
This was followed by transferring 600 μl of the supernatant to a fresh tube and
spinning again at 12000 rpm for 5 minutes at 4 oC. Finally, 500 μl of the clarified
supernatant was transferred to a fresh tube containing 600 μl of TRIzol LS reagent
(Invitrogen). The crude nuclear and cytoplasmic fractions in TRIzol were frozen at 80 oC until processed for RNA isolation.
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2.8 Total Cellular RNA Extraction
RNA was isolated from either total, nuclear, or cytoplasmic fractions using
the TRIzol or TRIzol LS reagent (Invitrogen). After resuspension of the cell pellets,
nuclear or cytoplasmic fractions in the lysis reagent, the samples were incubated at
room temperature for 5-10 minutes to attain complete lysis.

Next, 100 μl of

chloroform was added for RNA extraction per ml of TRIzol used. After mixing
thoroughly, the organic phase was separated from the aqueous phase containing the
RNA through centrifugation. The top aqueous layer was transferred to clean tubes
containing 600 μl of isopropanol. RNA was precipitated at room temperature for 10
minutes, pelleted by centrifugation at 13,000 rpm for 20 minutes at 4 oC. The RNA
pellets were left at room temperature to air dry for 30-60 minutes before
resuspending in RNase-free water. To ensure complete resuspension, RNA pellets
were vortexed briefly and incubated at 55 oC for 10 minutes before freezing at -80 oC
for further use.
2.9 Reverse Transcriptase (RT) PCR
After isolation, RNA was quantified by Nanodrop and 2-5 μg was treated
with Turbo DNase I (Invitrogen Life Technologies) in the presence of 40 U of
Recombinant RNasin (Promega) for 30 minutes at 37 oC to ensure DNA-free
preparations. The DNase I enzyme was inactivated using 1/10th volume Turbo
DNase Inactivation Reagent, while mixing occasionally at room temperature. The
DNased-RNA was transferred to fresh tubes after centrifugation and 1 μl was tested
by 30 cycles of PCR to test for the presence of contaminating genomic or plasmid
DNA using GAPDH (OFM24/25) and/or MMTV-specific primers (OTR671/672;
Table 2.2). The DNased-RNA was then used to synthesize cDNA in a reverse
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transcription reaction. First strand synthesis of cDNA was achieved by the addition
of 1.5 μg of poly(dT17) (OFM26) or random dodecamers and 0.5 mM
deoxynucleotide triphosphates (dNTPs). Primer annealing was carried out at 70 oC
for 5 minutes, followed by immediate incubation on ice for 5 minutes. Then 200 U of
Moloney Murine Leukemia Virus Reverse Transcriptase (M-MLV RT) (Invitrogen,
USA) and 40 U of RNase inhibitor was added in a 60 μl reaction for cDNA synthesis
at 37 oC for 1 hour. Freshly prepared cDNAs were aliquoted and stored at -80 oC,
while 1-2 μl was used to check for the quality of cDNA using spliced actin
(OTR580/581), unspliced actin (OTR581/582) and MMTV-specific primers
(OTR671/672) in a PCR reaction. The absence of unspliced β-actin in cytoplasmic
cDNAs was used to confirm the integrity of fractionation. All primers used in this
study are described in Table 2.2 and were commercially synthesized (Macrogen,
South Korea).
PCRs were performed using the following general conditions: initial
denaturation at 94 oC for 2 minutes, 30 cycles of denaturation at 90 oC for 45
seconds, primer annealing at 50-60 oC for 45 seconds depending upon the primer
melting temperature, and final extension at 72 oC for 45 seconds. The amplified PCR
products were analyzed by electrophoresis at 100 volts on 0.8-2% agarose gels
(Invitrogen Life Technologies), stained with ethidium bromide, and viewed using a
gel documentation system (UVP Biospectrum 610 Imaging System).
2.9.1 MMTV gene-specific RT-PCR
MMTV gene-specific RT-PCR were conducted on cytoplasmic and nuclear
cDNAs made from transient transfection of HEK293T cells with full-length genomic
clones of MMTV with hCMV promoter (SQ5-SQ15) to analyze the expression of
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unspliced and spliced mRNAs. For gRNA amplification, primers OFM112/OFM113
were used (Table 2.2) under the following PCR conditions: initial denaturation at 94
o

C for 3 minutes, 30 cycles of denaturation at 94 oC for 1 minute, primer annealing at

55 oC for 1 minute and extension at 72 oC for 1 minute with the final extension at 72
o

C for 5 minutes. For the PCR amplification of spliced MMTV mRNAs (Env, Rem,

and Sag), two sets of primers were used: one set for detecting spliced transcripts
from the LTR promoter (OFM112/OFM114), and another set for detecting spliced
transcripts from the env promoter (OFM115/OFM114) (Table 2.2) under the
following PCR conditions: initial denaturation at 94 oC for 3 minutes, 50 cycles of
denaturation at 94 oC for 1 minute, primer annealing at 55 oC for 1 minute and
extension at 72 oC for 2.5 minute with a final extension at 72 oC for 5 minutes.
2.9.2 Real Time quantitative PCR (qPCR)
Quantitative PCR was used to calculate the level of expression and transport
efficiency of Gag/Pol mRNA from the nucleus to cytoplasm. Human β-actin
Endogenous Control Assay, (VIC/MGB probe, Applied Biosystems, USA) was used
as the endogenous control to normalize Gag/Pol expression values for cDNA
quantity. Expression of Gag/Pol mRNA was quantified in nuclear and cytoplasmic
cDNAs in triplicates by a custom-made Taqman gene expression assay (Applied
Biosystems). The FAM/MGB-labeled probe in this assay bound within a region in
MMTV Gag (nts1729-1791) present in both the wild type and mutant clones and
outside the region of mutation.

Standard PCR conditions were used for the

amplification: 2-minute incubation with Uracil N-glycosylase at 50 oC, denaturation
at 94 oC for 10 minutes, 50 cycles of denaturation at 94 oC for 15 seconds and
annealing/extension at 60 oC for 1 minute. The relative quantification (RQ) values
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thus obtained were normalized to the endogenous β-actin control using the –ΔΔCt
method. These values were further normalized to the relative firefly luciferase
expression per μg of protein (RLUC/μg) to take into account differences in
transfection efficiencies, and reported relative to the mock sample.
2.10 mRNA Stability Assay
The mRNA stability analysis was performed on HEK293T cells transfected
with MMTV full length genomic constructs under the hCMV promoter using the
calcium phosphate kit method. The expression of Gag/Pol mRNA was inhibited 48
hours post transfection by treating the transfected cells with 5 μg/ml of Actinomycin
D (Sigma) transcription inhibitor. After treatment, cells were harvested at 0, 8, 16,
24, and 48 hours. At each time point, cells were harvested by trypsinization and
resuspended in 1 ml of 1X PBS before splitting into three parts: 50 μl of cell
suspension was aliquoted for firefly luciferase and protein quantification assay, 100
μl of cells were used for total RNA extraction, while 850 μl of cells were used for
subcellular fractionation to quantify the mRNA expression in cytoplasm and nucleus.
Cell pellets were stored at -80 oC for further processing.

The experiment was

repeated two-three times using different time points to harvest the cells and similar
results were obtained.
2.11 Western Blotting
Whole cell extracts for western blotting were prepared using the
radioimmunoprecipitation assay (RIPA) buffer (Sigma) supplemented with 50 µl of
β-mercaptoethanol (Sigma) and 100 mM Phenylmethylsulfonyl fluoride (PMSF
dissolved in isopropanol) per milliliter of buffer. Cells (2 x 106) were lysed for 10
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minutes on ice in 200 μl of RIPA buffer and centrifuged at 13,000 rpm in a bench top
microcentrifuge for 10 minutes at 4 oC to separate the nuclei and cellular debris. The
clear lysates were transferred to fresh tubes and total cellular protein quantified using
the Bradford reagent, as described earlier. An appropriate volume of each lysate (50
μg) was mixed with 5X SDS loading buffer (Sigma) and boiled for 5 minutes at 95
o

C for protein denaturation prior to loading onto 8-10% SDS polyacrylamide gels

(prepared using 29:1 ratio of acrylamide to bisacryl solution).
Proteins were transferred to 0.45 μm Protran BA85 nitrocellulose membrane
(GE Healthcare, USA) in transfer buffer (39 mM glycine, 48 mM Tris base, 1%
SDS, 20% methanol) overnight at 30 volts in cold room. Protein transfer was
checked with reversible Ponseau Stain and membranes were blocked in 5% non-fat
milk in 1X PBS with 0.1% Tween-20, PBST (Sigma) for 1 hour. After washing, the
membranes were incubated with specific primary antibodies diluted in 2% non-fat
milk in PBST for 1 to 4 hours at room temperature (or overnight at 4 oC), depending
upon the antibody. Membranes were washed thoroughly three times with PBST
buffer before incubation for 1 hour with horse reddish peroxidase (HRP)-conjugated
secondary antibodies diluted in 2% non-fat milk in PBST. Membranes were washed
again three times with PBST buffer to remove the non-specifically bound secondary
antibody. Final signal was detected using the ECL Plus western blotting substrate
(Thermo Scientific, USA) as recommended by manufacturer using Typhoon FLA
9500 (GE Healthcare).
2.11.1 Antibodies
The primary monoclonal antibodies for MMTV Gag/Pol, anti-MTV p27
produced in mouse (Blue 7) was a gift from Prof. Tatyana V. Golovkina (The
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University of Chicago, IL USA). The antibody for envelope protein detection, antigp52 produced in goat, was a gift from Prof. Jaquelin P. Dudley (The University of
Texas at Austin, TX USA). Monoclonal anti-β-actin peroxidase antibody produced
in mouse (A3854, Sigma) was used as a loading control in western blot experiments.
The HRP-conjugated anti-mouse and anti-goat secondary antibodies were obtained
from Sigma.
2.12 In-silico Analysis of Secondary Structure of MMTV 5’ UTR
The MMTV 5’ UTR RNA sequences were folded using the online available
tool Mfold (Mathews et al., 1999; Zuker 2003).

Mfold predicts the most

thermodynamically stable secondary structure that the RNA can fold by calculating
the minimum free energy of each structure; thus, the more negative the free energy,
the more stable the structure. These structures were analyzed for the predicted
structural differences due to the introduced deletions and substitutions between the
major spliced donor (mSD) and Gag start codon (ATG).

54

Chapter 3: Results
To address our hypothesis that there is a cis-acting sequence in the 5’ UTR of
MMTV similar to 3’ RmRE, a series of deletion and substitution mutations were
introduced in a small 24 nt region between mSD and gag start codon found
exclusively in the gRNA (Figure 3.1). Comparison of this sequence among various
MMTV strains revealed that it was a conserved part of the viral genome with only
the GR strain showing a two nucleotide variation (Figure 3.1).

Figure 3.1: Sequence alignment of the 5’ end of different MMTV strains
The shaded boxed region highlights the 24 nt region analyzed. Presence of a “.”
shows sequence identity, while differences are shown as capital letters.

The mutations were introduced in the context of the full-length proviral
genome using splice overlap extension (SOE) PCR (Gibbs et al., 1994) (Figure 3.2).
The generated mutants were confirmed through sequencing and used in stable
transfections to analyze their effect on nucleocytoplasmic transport of full-length
gRNA and its translation into Gag/Pol proteins. The constructs SA5 to SA9 are the
deletion mutants in which SA5 contains a complete deletion of the entire 24 nt
region, starting from the GT (mSD) and ending before Gag ATG. The mutation in
SA6 removes the first 12 nts which is the first half of the region, while SA7 mutation
removes 12 nts from the 3’ half of the region. SA8 removes the first 6 nt and SA9
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mutation removes 9 nt in the middle of the test region investigated. The next five
constructs, SA10-SA14, were the substitution mutants that contained heterologous
sequences in place of the deletions described in SA5-SA9 (Figure 3.2).

Figure 3.2: Illustration of the mutations introduced into the putative RmRE at the 5’
end of the MMTV genome
(A) Illustration of the MMTV genome with and without the hybrid (CMV/R/U5)
LTR. Locations of the 3’ RmRE as well as that of the putative 5’ RmRE are
demarcated on the genome with schematics of higher order structures. (B) Depiction
of mutations introduced between the mSD and Gag start codon (ATG) and cloned
into the full length wild type (WT) clone, HYB MTV (SA series of clones), or cloned
into MMTV with the hybrid hCMV/R/U5 5’ LTR (SQ series of clones). The
sequences in black represent the WT sequences, whereas the sequences in red
represent the mSD (GT) and Gag start (ATG). “-” represent the deleted sequences,
whereas sequences in blue denote substituted sequences.
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3.1 Stable Cell Lines Show Integration of MMTV WT and Mutant Constructs
The MMTV full-length WT (HYBMTV) and mutant genomic clones (SA5SA14) were electroporated into Jurkat T cells to make stable cell lines. Following
electroporation, the transfected cells were kept in media with hygromycin antibiotic
for 3-4 weeks to select the stable pool of cells. Genomic DNA was purified from
stably selected cells to check for the presence of WT and mutant MMTV genomes
using PCR with MMTV-specific primers (OTR671/OTR672; Figure 3.3). Presence
of PCR-amplified bands confirmed the presence of MMTV sequences in the gDNA
of our stable cell lines (Figure 3.4; Panel I).

Figure 3.3: Illustration of various MMTV transcripts expressed using specific splice
sites along with location of some of the primer pairs used in this study
(A) Schematic representation of MMTV genome. (B) MMTV genome with the
hCMV/R-UR promoter. (C) MMTV gRNA with the location of the different splice
sites, as well as the different transcripts produced from the use of these splice sites.
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The mapped primers show the location of some of the common primers used for this
study. For the sake of clarity, the words OTR and OFM have been omitted from the
primer names, showing only primer numbers.
The stable cell lines were also analyzed for RNA expression after isolation of
total RNA. Purified RNAs were converted into cDNAs and then analyzed with
MMTV-specific primers for the expression of MMTV mRNAs using primers in the
R/PBS region that are present in all MMTV mRNAs (Figure 3.3). Appearance of
MMTV-specific PCR-amplified bands in all cell lines confirmed the expression of
the WT and mutant viruses (Figure 3.4; Panel II).

Figure 3.4: The Jurkat stable cell lines reveal integration and expression of MMTV
genes
PCR analysis (I) shows the amplification of MMTV-specific sequences from gDNA
of WT and mutant stable cell lines using primers OTR671/OTR672. (II) RT-PCR
analysis of MMTV-specific mRNAs in WT and mutant stable cell lines using the
same primer set.
3.2 The Deletion and Substitution Mutants Show Variable Defects in mRNA
Expression
The stable WT and mutant MMTV-expressing cells were harvested and
fractionated into nuclear (NUC) and cytoplasmic (CYT) fractions. RNA was isolated
from each fraction, and treated with DNase I. After DNase treatment, RNA
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preparations were tested for the presence of any contaminating plasmid or gDNA by
setting MMTV- and GAPDH-specific PCRs, respectively. Lack of any amplification
confirmed that both the NUC and CYT fractions of MMTV mutant (SA5-SA14) and
WT (HYB MTV) RNA were deficient for any contaminating plasmid DNA (Figure
3.5A; Panels I & II) or gDNA (Figure 3.5A; Panels III & IV). The NUC and CYT
DNase-treated RNA fractions were then converted into cDNAs. First the NUC and
CYT cDNAs were analyzed for the integrity of fractionation by testing for spliced
and unspliced ß-actin mRNAs. Presence of clear spliced ß-actin signal in NUC as
well in CYT cDNA confirmed the quality of our cDNAs (Figure 3.5B; Panels I & II).
If the nuclear membrane integrity remained intact during fractionation, we should
amplify only the unspliced ß-actin in NUC and not in CYT cDNA samples. As
expected, the unspliced ß-actin band was observed in NUC cDNAs and barely in
cDNAs prepared from the CYT fraction, confirming the integrity of our RNA
fractionation (Figure 3.5B; Panels III & IV).
Finally, NUC and CYT cDNAs were analyzed for MMTV gene expression
using MMTV-specific primers (OTR671/OTR672) within the R-PBS region
upstream of the mSD so that all MMTV mRNAs from the LTR promoter can be
detected (Figure 3.3). Successful amplification could be observed in all mutant and
WT NUC cDNAs except SA5 and SA6 mutants in which amplification was below
the level of detection (Figure 3.5C; Panel I). SA5 contains a complete deletion of the
24 nt region, whereas SA6 contains a deletion of the first 12 nt in the investigated
region (Figure 3.2).

On the other hand, CYT cDNAs showed amplification in

deletion mutants, but not in the substitution mutants except for a weak signal in
SA12, when efficient amplification could be observed in the WT (Figure 3.5C; Panel
II). These NUC and CYT cDNAs were then analyzed for gRNA expression, with
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Gag/Pol-specific primers OFM112/OFM113. Consistent with our earlier observation,
RT-PCR revealed the absence of genomic full-length mRNAs in SA5 and SA6
(Figure 3.5C; Panel III). Interestingly, no gRNA in the NUC fraction of any of the
substitution mutants could be observed either, while no expression of any of the
constructs could be observed in CYT fraction except for WT (Figure 3.5C; Panel
IV). These results reveal that, 1) MMTV-specific mRNAs were being expressed in
all mutant cell lines, but the substitution mutants were defective for their export to
the cytoplasm, and 2) most deletion mutants (other than SA5 and SA6) could express
gRNA in the nucleus, but these mutants were defective for their RNA export to the
cytoplasm. Together, these results suggest defects in the expression and/or transport
of gRNA in these mutants.
3.3 The Paired Deletion and Substitution Mutants (SA5/SA6 and SA10/SA11)
are Deficient in Gag/Pol Protein Expression
To determine the effect of the observed defects in full-length mRNA
expression on protein, total cellular proteins were tested in western blots for the
expression of Gag proteins which are expressed from the full-length, unspliced RNA.
Our results revealed that SA5 & SA6 and their corresponding substitution mutants,
SA10 & SA11, were deficient in Gag protein expression, whereas Gag protein
expression could be observed in the WT and other mutants, albeit at low levels in
SA13 and SA14 (Figure 3.6). The fact that Gag proteins could be expressed when
mRNA could not be detected by PCR suggested that a combination of effects were
being exerted on nuclear export, stability, and translation of the MMTV mRNAs,
revealing an important role of this region on MMTV gene expression.
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Figure 3.5: Effect of mutations on MMTV gRNA expression in Jurkat stables
(A) PCR analysis of NUC and CYT RNAs following DNase treatment with Panels I
& II: MMTV-specific primers (OTR671/OTR672). Panels III & IV: GAPDH
primers. (B) RT-PCR analysis of NUC and CYT samples with Panels I & II: spliced
β-actin primers (OTR580/OTR581), and Panels III & IV: unspliced β-actin primers
(OTR582/OTR581). (C) RT-PCR analysis of NUC and CYT samples for Panels I &
II: all MMTV mRNAs (OTR671/OTR672), and Panels III & IV: full length gRNAs
(OFM112/OFM113) in the WT and mutants stable cell lines.
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Figure 3.6: Expression of MMTV Gag/Pol proteins is affected in some of the mutant
Jurkat stable cell lines
Western blot analysis of stable cell lines expressing the WT and mutant MMTV
constructs showing reduced Gag/Pol protein expression in some of the mutants in
comparison to WT when analyzed with Gag-specific polyclonal anti-MMTV p27
antibody. Blot was also probed with anti-β-actin antibody which served as a loading
control.

To ensure that some of the results being observed were not due to differences
in the number of proviral copies integrated into the genome, we conducted real time
PCR on gDNA isolated from the stable cell lines using our custom-made Taqman
assay that binds in the U5 region of the viral genome (Mustafa et al., 2012; Aktar et
al., 2014). After normalizing the data with the endogenous β-actin gene signal using
the -∆∆CT method, the qPCR analysis revealed variable levels of integration of the
mutant clones in the different cell lines with SA7 and SA11 showing ~7-fold more
integrations than observed in the WT (Figure 3.7A). Using the same assay, the RNA
expression (all MMTV mRNAs) of the clones was quantitated using total cellular
RNA (Figure 3.7B) and then normalized to the integrations observed (Figure 3.7C).
This analysis revealed that SA6 and its substitution mutant, SA11, were the most
detrimentally-affected mutants, followed by some others. However, based on the
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Figure 3.7: Quantitative PCR analysis of virus expression in stable cell lines
Real time PCR was conducted on (A) 50 ng Gdna, and (B) cDNAs from the same
Jurkat stable cell lines expressing the WT and mutant MMTV clones. The
primer/probe in this assay should detect gDNA and all MMTV transcripts from the
LTR promoter in these samples. (C) Normalization of the MMTV RNA expression
relative to the integration level in the Jurkat stable cell lines. Real time PCR was
conducted using a custom-made Taqman assay (Mustafa et al., 2012; Aktar et al.,
2014).
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variability of integrations observed, combined with the results of RNA expression
that showed a combination of effects on viral gene expression discussed earlier, led
us to redesign our vectors to achieve a much higher level of expression, which we
felt was necessary to enable us to address the hypothesis at hand.
3.4 Re-design of MMTV Genomic Constructs
MMTV promoter has a low basal activity in most cell types other than the
mammary glands. To allow us to study the effect of the 5’ UTR mutations on
MMTV gene expression in an efficient manner, we decided to replace the U3 region
that contains the MMTV promoter with the constitutively active hCMV promoterenhancer (Figure 3.2). This design has been used successfully to express MMTV
subgenomic RNAs for packaging studies in a single round of replication assay (Rizvi
et al., 2010; Mustafa et al., 2012; Aktar et al., 2014).

Wild type and mutant

constructs containing the desired mutations (SQ5-SQ14) were transfected into the
HEK293T cells along with luciferase expression vector, pGL3C to monitor
transfection efficiencies. Two to three days post transfection, the transfected cells
were harvested and total cellular RNA as well as RNAs from nuclear and
cytoplasmic fractions, and protein lysates were prepared for RNA and protein
expression analysis, as described earlier.
3.5 The Region Between the mSD and Gag ATG Regulates mRNA Levels
RNA samples prepared from the nuclear (NUC) and cytoplasmic (CYT)
fractions were treated with DNase I to rule out the possibility of amplification signal
from genomic or plasmid DNA contaminating the RNA fractions. This was followed
by PCR amplification using GAPDH-specific and MMTV-specific primers. Samples
treated with DNase I showed no amplification, confirming that all RNA samples
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were devoid of any contaminating DNA (Figure 3.8A; Panels I-IV). Next, cDNAs
were prepared and analyzed for the quality of our subcellular fractionation by using
spliced (OTR580/581) and unspliced ß-actin-specific primers (OTR581/582). As
expected, both spliced and unspliced ß-actin could be observed in NUC fractions,
while CYT fractions revealed low level of unspliced products, suggesting slight
leakage between the two compartments during fractionation, but it was quite
consistent in all the samples and not enough to affect the interpretations of our results
(Figure 3.8B; Panel I-IV).
3.5.1 Mutations in SQ5/SQ6 and SQ10/SQ11 clones detrimentally affect fulllength mRNA levels
RT-PCR analysis of full-length mRNA expression using primers in the 5’
UTR both upstream and downstream of the mSD (OFM112/OFM113) revealed
compromised expression of full-length mRNA in SQ5 and SQ6 deletion and
corresponding substitution mutants (SQ10 and SQ11) in both NUC and CYT cellular
fraction (Figure 3.8C; Panel I & II). This was in agreement with our earlier results
with the Jurkat stable cell lines with the constructs containing MMTV LTR (Figure
3.5C). Next, the expression of all MMTV mRNAs was determined using the primer
pairs OTR671/OTR672 that bind in a region common to all MMTV mRNAs (within
R and PBS of the 5’ end of the viral genome; Figure 3.3). A slight decrease in all
MMTV mRNAs expression was observed in the same set of mutants as mentioned
above, compared to WT despite 30 cycles of PCR amplification (Figure 3.8C; Panels
III & IV). We attribute this slight decrease to the defect in gRNA detection observed
with primers OFM112/OFM114 and not reduction in spliced mRNAs themselves
(Figure 3.8C; Panel I & II).

Figure 3.8: Region between mSD and Gag ATG is important for the expression of MMTV mRNAs
(A) DNase treatment of nuclear (NUC) and cytoplasmic (CYT) RNAs following RNA extraction. Panel I & II: MMTV-specific primers
(OTR671/OTR672) for plasmid DNA contamination; Panel III & IV: Cellular GAPDH primers for genomic DNA contamination. (B) RT-PCR
amplification of spliced and unspliced β-actin mRNA as a subcellular-fractionation control. Panel I & II: Spliced mRNA amplification of β-actin
in NUC and CYT fractions, respectively. Panel III & IV: Unspliced mRNA amplification of β-actin in NUC and CYT cDNAs. (C) RT-PCR
analysis of: Panel I & II, full-length (OFM112/OFM113) and Panel III & IV, all MMTV mRNAs (OTR671/OTR672) in NUC and CYT cDNA
fractions. (D) RT-PCR analysis of other MMTV mRNAs using Panel I & II: OFM112/OFM114 primers that detect spliced mRNAs from the
LTR promoter, Panel III & IV: OFM115/OFM114 primers that detect spliced mRNAs from the Env promoter.
65

66
Finally, we analyzed the expression of MMTV spliced mRNAs using primers
specific for different transcripts such as Env, Sag and Rem mRNAs expressed either
from

the

LTR

(OFM112/OFM114)

or

the

intragenic

Env

promoters

(OFM115/OFM114) (Figure 3.3). Amplification with LTR-promoter-specific
primers that should only pick up the spliced Sag and Rem mRNAs under
theconditions used, revealed that the same subset of mutants affected earlier
(SQ5/SQ6 & SQ10/SQ11) showed a complete absence of MMTV-specific spliced
gene expression compared to WT in both the NUC and CYT fractions except for a
slight signal in CYT from SQ6 & SQ11 (Figure 3.8D; Panels I & IV).

This

observation suggested that SQ5/SQ6 and SQ10/SQ11 were defective for not only the
full-length, but also spliced mRNA expression. However, it was puzzling that the
two primer sets (OTR 671/OTR672 and OFM112/OFM114) that should technically
pick up “all MMTV mRNAs” gave different results in the mutants: a slight reduction
in mRNA expression with the first set of primers, but a nearly complete lack of
expression with the latter primer set compared to the WT. This could be explained if
one argues that there is a potential problem(s) with mRNA extension since the first
primer set bound within the 5’ end of the mRNAs (within R/PBS), while the second
set bound both ends of the mRNAs (upstream of the mSD and within 3’ U3; Figure
3.3).
To quantify the defect in gRNA expression being observed, we established a
custom made Taqman assay. This assay employed primers and a FAM-MGB-labeled
probe in the region downstream of mSD and therefore present only in MMTV gRNA
but away from the site of mutations (Figure 3.3). It was used along with a
commercially available human β-actin VIC-MGB assay (ABI) as an endogenous
control. As can be seen from the amplification curves, mutants SQ5, SQ6, SQ10 &
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SQ11 showed much delayed amplification (in the ~23 CT range) compared to that
observed for the WT or other mutants (in the ~15 CT range) in both the NUC and
CYT fractions (Figure 3.9A & C). This was despite the fact that all constructs
showed very similar human β-actin amplifications in both fractions within 1-2 CTs
of each other (Figure 3.9B & D).
Relative quantification (RQ) of the gRNA expression between the mutants
and WT was conducted by normalizing the MMTV expression with the endogenous
β-actin control. This was followed by further normalization of the RQ values with
luciferase expression observed in each culture/μg protein to normalize for differences
in transfection efficiency of the various mutants.

As can be seen, severely

compromised expression of gRNA was observed in SQ5, SQ6, SQ10 and SQ11
mutants in both the NUC and CYT compartments compared to the WT or other
mutants (Figure 3.10A & B).
3.6 Nucleocytoplasmic Transport of Full-Length gRNA is Not Affected in the
Compromised Mutant Clones
Next, we analyzed whether the nucleocytoplasmic transport of full length
gRNA was affected in these mutants. This was achieved by calculating the
NUC/CYT ratio of full-length gRNA levels using relative normalized RQ values
(normalized to β-actin as well as for transfection efficiency). As can be seen, the
relative transport efficiency of deletion as well as substitution mutants appeared to be
equivalent or better (SQ9, SQ11, SQ13 and SQ14) when compared to the WT
(Figure 3.10C). The relative transport efficiency was also calculated in terms of
percentage to verify the observed results and accuracy of the above method.

Figure 3.9: qPCR analysis of MMTV full-length gRNA reveals reduced mRNA levels in SQ5/SQ6 and SQ10/SQ11
Relative quantification of MMTV full-length gRNA and β-actin mRNA levels in HEK293T cells transfected with wild type (WT) and MMTV
mutant clones. (A) Nuclear levels of full-length gRNA. (B) Nuclear levels of β-actin endogenous mRNA. (C) Cytoplasmic levels of full-length
gRNA. (D) Cytoplasmic levels of β-actin endogenous mRNA.
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Figure 3.10: qPCR analysis of full-length gRNA levels in the nucleus and cytoplasm and its nuclear export efficiency
The bar charts represent levels of full-length gRNA in the (A) nuclear (NUC) and (B) cytoplasm (CYT) fractions of mutant- and WT-transfected
HEK293T cells. (C) Nuclear to cytoplasmic transport ratio of full-length gRNAs. (D) Percentage efficiency of nucleocytoplasmic transport of
full-length gRNA in the mutants compared to WT.
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To calculate the percentage of relative full-length gRNA transport to CYT,
the CYT expression of gRNA was divided by the total of CYT and NUC full-length
mRNA levels and multiplied by 100 (Figure 3.10D). Similar to the transport ratio of
full-length gRNA from NUC to CYT, the percentage transport efficiency appeared
comparable to WT levels or in fact enhanced for some of the mutants.

This

confirmed our results that the deletion or substitution of region under investigation
did not affect the transport of full length gRNAs from the nucleus to cytoplasm
(Figure 3.10D). On the other hand, specific mutations (in mutants SQ5/SQ6 &
SQ10/SQ11) did affect the transcription or stability of the gRNAs to begin with
(Figure 3.8C; Panels I & II, Figure 3.9A & C and Figure 3.10A & B).
3.7 SQ5/SQ6 and SQ10/SQ11 are Defective for Gag/Pol & Env Protein
Expression
Next, we wanted to determine the effect of introduced mutations on the
translation of the Gag structural proteins expressed from the gRNA. Total cellular
protein lysates were prepared from transiently transfected HEK293T cells with WT
and mutant clones (SQ5-SQ15). Western blot analysis of these lysates for protein
expression (using antibodies for either MMTV Gag (α-p27 Blue 7) or Env (α-gp52))
revealed a complete abrogation of protein expression in these mutants (SQ5, SQ6,
SQ10 and SQ11) when compared to the WT (Figure 3.11A & B), the same set of
mutants that showed a defect in full-length or spliced mRNA levels compared to WT
(Figures 38-3.10). This was despite loading equal amounts of protein of good quality
as assessed by analyzing β-actin protein expression (Figure 3.11A & B). These
results corroborate the observations made in the Jurkat stables (Figure 3.6) and
suggest that either there is no protein expression either due to defects in translation of
structural proteins in the affected mutants (SQ5/SQ6 & SQ10/SQ11), or more likely,
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due to reduced expression of the full-length mRNA in the nucleus in the same set of
mutants.

Figure 3.11: SQ5, SQ6, SQ10 and SQ11 are defective for Gag/Pol and Env protein
expression
Western blot analysis of HEK293T cells transfected with the WT and mutant clones.
(A) Gag specific α-MTV p27 (Blue 7) antibody. (B) Blotting with Env-specific
antibody (α-MTV gp52) with human β-actin serving as loading control in both gels.
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3.8 MMTV Full-Length Gag/Pol mRNAs Were Stable in Mutants with
Compromised mRNA Levels and Protein Expression
Earlier, we observed significantly low expression of spliced and unspliced
mRNAs of MMTV in cytoplasmic as well as in nuclear fraction of SQ5, SQ6, SQ10
and SQ11 mutants compared to WT (Figure 3.8-3.10). Therefore, we asked whether
the reduced mRNA levels in the nucleus could be due to mRNA instability. To
address this question, the two mutants with the most drastic effect on mRNA
expression, SQ5 and SQ6 were transiently transfected into HEK293T cells for
stability analysis. The transfected cells were treated with actinomycin D (a classical
transcription inhibitor) 48 hours post transfection. These cells were then processed
for subcellular fractionation at 0, 8, 16, 24 and 48 hours post treatment. Total, NUC,
and CYT RNA was isolated and analyzed for the expression of gRNA as described
earlier.
Briefly, DNase I treatment of the RNAs followed by GAPDH PCR confirmed
the absence of residual contaminating DNA in all three fractions (Figure 3.12A).
After confirming the absence of any contaminating DNA in these fractions, cDNAs
were synthesized.

Next, the nuclear cDNAs were analyzed for the stability of

spliced, unspliced ß-actin and all MMTV mRNAs as a control. As reported in
literature (Johnson et al., 1991; Leclerc et al., 2002), spliced ß-actin mRNAs were
stables up to 48 hours post treatment, whereas unspliced ß-actin mRNAs were
unstable within 8 hours of treatment with actinomycin D (Figure 3.12B; Panel I &
II). On the other hand, we could detect all MMTV mRNAs in samples treated up to
48 hours, revealing the overall stability of MMTV messages using the primer set
OTR671/OTR672 (Figure 3.12B, Panel III). Next, the cDNAs were analyzed for
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Figure 3.12: MMTV full-length gRNA is stable up to 48 hours after treatment with
transcription inhibitor, Actinomycin D
HEK293T cells transfected with mutant and WT MMTV constructs, and treated with
actinomycin D for various time points and NUC, CYT, and total extracted RNAs
were DNase treated and analyzed for (A) DNA contamination using GAPDHspecific primers. (B) RT-PCR analysis of NUC cDNAs using spliced and unspliced
ß-actin as well as all MMTV (OTR671/OTR672) primers. (C) RT-PCR analysis of
MMTV full-length Gag/Pol mRNA post treatment with actinomycin D in NUC,
CYT as well as total cDNA samples using primer pair OFM112/OFM113.
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stability of the full-length unspliced gRNA specifically, using gRNA specific primers
(OFM112/OFM113). Our data revealed that overall SQ5 and SQ6 expressed much
lower levels of full-length gRNA from the start in the nucleus compared to the WT
(Figure 3.12C); however, once expressed, the mRNA was quite stable up to 48 hours
and transported successfully to the cytoplasm with only slight effects, if any, on
stability (Figure 3.12C).
3.8.1 Quantification of full-length gRNA levels confirms its stability in both the
fractions
To quantify the full-length gRNA levels in the various fractions with time, we
tested the NUC, CYT, and total cDNA samples using our qPCR Taqman assay
designed for gRNA as described above. The RQ values obtained for the gRNA
levels were normalized to the endogenous β-actin expression as well as the
transfection efficiency using luciferase expression/μg protein of each construct and
plotted in the form of bar graphs relative to the WT full-length gRNA. Analysis of
the full-length gRNA levels after treatment with actinomycin D revealed that SQ5
and SQ6 were completely deficient in mRNA expression from the start at “0” hour in
the nucleus itself (Figure 3.13). Together, these data reveal that the defect being
observed in the mutants was not due to the stability or nuclear export of the
expressed gRNAs; rather it was due to the initial transcription of the full-length
gRNAs itself.
3.9 The 5’ Cis-acting Element is Not Responsive to MMTV Rem
Since we had hypothesized that the cis-acting element under study could be
an additional 5’ Rem-responsive element, we next asked whether we could detect
any “Rem- responsive” activity in this region employing a functional assay. This was
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accomplished by taking advantage of an earlier luciferase-based reporter construct
(pHMΔeLTRluc) that was used to study the Rem-responsiveness of MMTV 3’ LTR
(Mertz et al., 2005). This construct expresses the Renilla luciferase from a CMV
promoter surrounded by a splice donor and acceptor from MMTV. An artificial ScaI
site was engineered downstream of the luciferase gene, and upstream of the SV40
poly A site that was used for transcriptional termination (Figure 3.14). The WT or
mutant 5’ cis-acting element (from R/U5 to the first 35 nts in gag) from the different
mutant clones were PCR-amplified with flanking ScaI sites and cloned into the
artificial ScaI site introduced into pHMΔeLTRluc (Figure 3.14).

The construct

works on the premise that if it has a Rem-responsive element in cis (such as our 5’

Figure 3.13: Lack of MMTV full length gRNA in the nucleus from time zero
suggests defects in transcription
qPCR analysis of WT full-length gRNA up to 48 hours post actinomycin D treatment
in (A) nuclear, (B) cytoplasmic, and (C) total cDNAs prepared from HEK293T cells
transfected with the listed clones.
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Figure 3.14: Design of the dual reporter construct for Rem-responsiveness
Design of the WT (SQ17) and mutant (SQ18-SQ21) luciferase constructs tested in
transient transfections of human and mouse cell lines in combination with Rem
(MMTV) and Tat (HIV) expression plasmids.

cis-acting element), it should rescue the Luciferase mRNA from splicing by the
flanking splice sites, leading to successful luciferase expression. Thus, this construct
was co-transfected with a Rem-expression vector, GFP-Rem (Mertz et al., 2005)
along with the firefly luciferase expression vector, pGL3C, to monitor both Remresponsiveness and transfection efficiencies.
Test of the wild type or a deletion mutant with the entire 24 base pair region
deleted (SQ18) in this assay revealed that whilst the original vector was Remresponsive in HEK293T cells as can be seen by a spike in Renilla luciferase (RLUC)
activity in HMRluc, the mother construct that contained the 3’ RmRE (Mertz et al.,
2005), neither the WT nor the complete deletion mutant clone (SQ18) could express
any RLUC activity (Figure 3.15A). The same assay was repeated in two other cell
lines which are permissive for MMTV expression, the mouse mammary epithelial
cell line HC11 (Figure 3.15B) and the human Jurkat T cells (Figure 3.15C) to ensure
that the lack of response was not due to the lack of any cellular factors needed for
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Figure 3.15: The sequence at the 5’ end of MMTV genome is neither Rem nor Tat
responsive
(A-C) Dual luciferase assay was used on lysates from three cell lines transfected with
either the wild type (WT) or deletion mutant clone SQ18 in the presence of Rem- or
Tat- expression vectors Rem-GFP (Mertz et al., 2009a) or SV2-Tat (Kao et al., 1987;
Rice and Mathews, 1988), respectively.
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this activity. However, in all cases, no response to Rem was observed when the
mother construct, HMRluc, was responsive in all cases. Since normal mammary
epithelial cells are the most permissive cells for MMTV infection and no luciferase
activity could be observed in these cells, our results suggest that the 5’ cis-acting
element tested in this assay was not Rem-responsive.
3.10 The 5’ Cis-acting Element is Not Responsive to HIV-1 Tat
Earlier work by Dudley and colleagues has shown that retrovirally-encoded
proteins analogous to MMTV Rem such as HIV-1 Rev and HTLV Rex could interact
with the 3’ RmRE to facilitate the expression of viral genes (Mertz et al., 2009a).
Since one of the most drastic effects that we observed in our mutant clones was the
effect on the transcription of MMTV full-length genomic RNAs (Figures 3.8 and
3.10), we questioned whether MMTV gene expression may require either a viral or
cellular factor analogous to HIV-1 Tat rather than MMTV Rem to trans-activate its
gene expression by interacting with our cis-acting element.

To address this

possibility, we decided to test the ability of HIV-1 Tat to trans-activate gene
expression from the same RLUC expression constructs as tested in Figure 3.14.
Transient transfections of a Tat-expression vector (SV2-Tat, a kind gift from Prof.
Andrew Rice, Baylor College of Medicine, Houston, TX, USA) with wild type or
mutant (SQ18) RLUC clones revealed that none of the constructs could activate
Renilla luciferase expression in three different cell lines, namely HEK 293T, HC11,
or Jurkat cells (Figure 3.15 A-C). This observation revealed that HIV-1 Tat also
does not interact with the 5’ cis-acting element under investigation under the
conditions used. Use of the three cell lines further suggests that these cell lines do
not express a cellular factor that can interacts with this element.
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This observation is quite puzzling since either a virally-encoded (other than
Rem) or cellular factor should have been involved in this process. It is possible that
the negative results we have obtained are due to potential problems with vector
design (Prof. JP Dudley, University of Texas at Austin; Personal Communications).
Therefore, we have redesigned a new set of vectors to address this question (see
Future Directions).
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Chapter 4: Discussion and Future Directions
4.1 Discussion
The study presented in this thesis investigated the hypothesis that MMTV
may have two RmREs in its genome: the classical one at the 3’ end present in all the
mRNAs and regulating their translation, and a putative one at the 5’ end, present
only in the genomic RNA and regulating its nuclear export. Such an arrangement of
responsive elements of virally-encode transport proteins has been observed in HIV-1
as well where another putative Rev binding site has been mapped at the 5’ end of the
genome (Gallego et al., 2003; Greatorex et al., 2006). This hypothesis stemmed
from our earlier observation when MPMV CTE was used to express MMTV Gag/Pol
independent of the Rem/RmRE system (Rizvi et al., 2009). Test of these constructs
revealed that while CTE was critical for the translation of Gag/Pol proteins,
surprisingly, it was not required for the nucleocytoplasmic transport of MMTV
Gag/Pol mRNAs.
This raised another question as to where would Rem come from since these
constructs contained only gag/pol genes. A closer look at our vector design showed
that it not only contained the Gag/Pol ORFs, but also part of Env and exon 2 of Rem
(Figure 3.3). Thus, the expression vector had MMTV sequences that contained not
only the 5’ cis-acting element (the putative second RmRE) that we interrogated in
this study, but also 203 amino acids of the Rem protein, a region clearly shown to be
sufficient for Rem function (Mertz et al., 2005 and 2009b). In fact, mere first 98
amino acids of Rem, also known as MMTV signal peptide (MMTV-SP) are
sufficient not only for its nuclear cycling, but also its transport and post-transport
functions (Mertz et al., 2005 and 2009a &b; Byun et al., 2012). This part of Rem
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includes the nuclear localization signal (NLS), an arginine-rich RNA binding domain
(ARM), as well as the nuclear export signal (NES) (Mertz et al., 2005). In contrast
to HIV-1, MMTV Rem and Env proteins are expressed from the same reading frame
and in fact, Rem is actually a truncated version of Env (Mertz et al., 2005; Indik et
al., 2005). Thus, both proteins share the signal peptide as well (Mertz et al., 2005).
Not only that, the remaining C-terminus of Rem is actually a negative regulator of
Rem nucleocytoplasmic transport function (Mertz et al., 2005), a region that was
absent in the Gag/Pol expression constructs studied earlier (Rizvi et al., 2009), but
present in the constructs studied here.
4.1.1 Deletion of the 5’ cis-acting element affects MMTV gRNA expression in
both stable and transient cell lines
Therefore, to address our hypothesis, we generated a series of deletion and
substitution mutations in a small 24 nts sequence between the mSD and gag start
codon (ATG) in the 5’ UTR of MMTV genome (Figure 3.2). The selection of this
region was based on its exclusive presence in the unspliced RNA transcript in
comparison to other partially and fully spliced transcripts (Figure 3.3). Test of these
constructs in Jurkat stable cell lines showed significant reduction in full length
gRNA expression in subcellular fractions of two paired deletion and substitution
mutants (SA5/SA6 and SA10/SA11) (Figure 3.5C; Panels III & IV). In addition, we
also observed defective expression of Gag/Pol proteins in the same set of mutants
(Figure 3.6) which suggested that this region had a profound effect on the unspliced
mRNA expression. These results are also in agreement with earlier observations that
reported that the 5’ leader sequence of MMTV can enhance MMTV env and reporter
luc gene expression from MMTV vectors (Hohenadl et al., 2012).
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Since stable Jurkat cell lines exhibited low levels of MMTV expression due
to the weak MMTV promoter in mutant clones, the MMTV U3 region containing the
viral promoters was replaced with the strong constitutively-active hCMV promoter in
the WT and mutant constructs to resolve the underlying problem of low gene
expression (Figures 3.2 and 3.3).

This allowed an in-depth analysis of these

constructs in transient transfections in HEK293T cells, circumventing the additional
caveat of variable proviral integrations in different stable cell lines (Figure 3.7). RTPCR and qPCR-based analyses confirmed the significant reduction in full length
gRNA observed in the same set of mutants as in the stable cell lines, SQ5/SQ6 and
SQ10/SQ11 (Figures 3.8-3.10).

Furthermore, we also observed compromised

expression of spliced MMTV transcripts from both the LTR and env promoters
(Figure 3.8D).
4.1.2 Removal of the 5’ splice donor is not the reason for the observed effect of
the mutations
The debilitating effects that were observed in the two deletion mutants SQ5
(or SA5) and SQ6 (or SA6) were not due to the loss of the splice donor site, GT, in
these constructs that has been reported to affect MMTV gag gene expression (Figure
3.2) (Boeras et al., 2012). Boeras and colleagues had observed that introduction of a
synthetic gag gene without splice sites allowed its expression in the cytoplasm, but
expression of a gag gene from an expression vector required not only an intact
Rem/RmRE export system, but also functional splice sites flanking the gag gene
(Boeras et al., 2012).

In our case, the deletion in SQ5 removed the entire 24 nts

region, including the mSD other than the Gag ATG, while the deletion in SQ6
removed the first 12 nts in this region, including the mSD (Figure 3.2). Deletion of
the mSD should not have been the reason for the disruption in expression since SQ8
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also deleted the mSD (GT) but showed WT levels of unspliced and spliced RNAs
expressed from the same set of mutants. A closer look at the sequences revealed that
the GT was actually recreated in SQ8 due to the deletion, perhaps compensating for
the loss of the native GT. However, Gag/Pol expression defect was observed in the
two corresponding substitution mutants as well, SQ10 (or SA10) and SQ11 (or
SA11), mutants that had random substitutions in the deleted region, but maintained
the mSD (Figure 3.2). Thus, the expression defect observed was sequence-specific
and related to the deletion or substitution of an important cis-acting element (other
than the splice sites) required for gene expression in MMTV.
4.1.3 Nucleocytoplasmic transport is not affected by the 5’ cis-acting element
Quantitation of the nucleocytoplasmic transport of full-length gRNA in the
subcellular fractions revealed that loss of gRNA expression was not a function of
compromised nuclear to cytoplasmic transport efficiency of these mutant mRNAs
(Figures 3.10C & D). Instead, the cytoplasmic full-length gRNA expression was
similar to the expression in nuclear fractions of the affected mutants or in fact better
in some of the substitution mutants (Figure 3.10A & B). Likewise, the nuclear to
cytoplasmic ratio of relative full-length gRNA expression normalized for transfection
efficiency reflected either the wild type or better levels of transport in all the mutants
(Figure 3.10C). In light of these results, our initial hypothesis that transport of fulllength gRNA being regulated by this 5’ cis-acting element due to its exclusive
presence in full-length unspliced mRNA seems to have been challenged. These
finding are in agreement with the observations of Zhang and colleagues who also
have observed no significant role of MMTV 5’ UTR on cytoplasmic Gag mRNA
levels when compared to constructs containing the MPMV CTE (Zhang et al., 2015).
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4.1.4 Mutations in the cis-acting element abrogates translation of the Gag/Pol
and Env proteins
As mentioned, it has previously been shown that efficient translation of Gag
mRNA requires functional splice sites in addition to the regulatory protein Rem with
its cognate binding partner RmRE (Boeras et al., 2012). In conjunction, in the
absence of Rem, the presence of 5’ UTR or MPMV CTE has also shown to enhance
MMTV Gag protein translation (Zhang et al., 2015). Thus, we compared Gag
expression in our mutant clones with the WT through western blot analysis using
monoclonal Gag-specific antibodies.

No Gag expression was observed in the

affected mutants (SA5, SA6, SQ5 and SQ6 and their corresponding substitutions)
both in the stable cells (Figure 3.6) as well as in transiently transfected HEK293T
cells (Figure 3.11A). This effect on Gag translation could partially be attributed to
the disruption in the function of an internal ribosome entry site (IRES) observed in
the 5’ UTR of MMTV (Vallegos et al., 2010), which has putative binding sites for
polypyrimidine tract-binding protein (PTB) upstream to our region of interest
(Cáceres et al., 2016). IRES have been shown to play a role in translation of
downstream reporter genes as well (Vallegos et al., 2010). In addition to IRES,
presence of post-transcriptional control elements (PCEs) at the 5’ end of genomes of
retroviruses have been shown to play a role in enhancing protein expression
(reviewed in Bolinger and Boris-Lawrie, 2009). PCE is a RNA stem loop structure
that has been shown to affect the downstream reporter gene expression at the posttranscriptional levels (Roberts and Boris-Lawrie 2000) while interacting with RNA
helicase A (Hartman et al., 2006) to support polysomal attachment of mRNA. We
feel that in our case, the difference in expression observed was more profound at the
transcriptional level and consequently the translation of these mutant RNAs could be
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below the limit of detection rather than disruption in function of any of the putative
PCE that acts at post-transcriptional levels.
4.1.5 The 5’ cis-acting element affects the transcription of gRNA
As mentioned above, instead of translational defects, we think that the
compromised Gag/Pol protein expression could be attributed to transcriptional
defects caused by the mutations in this 5’ cis-acting region of interest. This is based
on the observation that MMTV Env protein expression was also found to be affected
and in the same set of mutants (SQ5/SQ6 & SQ10/SQ11) (Figure 3.8D), although
Env mRNA expression is reported not to be affected by the 3’ RmRE that is present
in our mutants (Indik et al., 2005; Müllner et al., 2008). This observation is different
from what has been observed in the case of HIV-1 where the partially spliced Env is
actually Rev/RRE-dependent (Hope, 1999; Pollard and Malim, 1998). In the case of
MMTV, whereas expression of gRNA was shown to be sensitive to leptomycin B (an
inhibitor of CRM1-dependent nuclear export), revealing that it is using the CRM1
pathway for RNA export, the expression of partially spliced Env RNA transcript was
not affected, suggesting that Env mRNA nuclear export used a different mode of
transport (Müllner et al., 2008). Thus, the fact that Env expression was also affected
suggests that the effect we are observing is at the transcriptional level where the fulllength gRNA is not being efficiently expressed to start with. Therefore, not only
gRNA, but expression of all other partially spliced and multiply-spliced RNAs was
affected by the introduced mutations (Figure 3.8D; Müllner et al., 2008). These data
suggest the presence of a transcriptional factor/enhancer binding site downstream of
the LTR. Such a location for transcription factor binding sites seems unique since a
quick search of literature did not reveal any published articles reporting this location.
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4.1.6 Stability of gRNA is not affected by the 5’ cis-acting element
Intrigued by these observations, as well as in the light of earlier reports that
have shown that the 5’ leader sequence of MMTV plays a role in enhancing the
stability of Env transcripts (Hohenadl et al., 2012), we next tested the effect of the
mutations on mRNA stability using the transcription inhibitor Actinomycin D. Our
analysis revealed that the unspliced gRNA was quite stable in both the nuclear and
cytoplasmic fractions, at least up to 48 hours post treatment with Actinomycin D
(Figures 3.12C and 3.13). Compared to this, our control unspliced β-actin mRNA
disappeared within a few hours of treatment (< 8 hours; Figure 3.12B), in agreement
with its stability reported in literature (Johnson et al., 1991; Leclerc et al., 2002).
Thus, an effect on stability of the gRNA was ruled out by the 5’ cis-acting element
examined in this study.
4.1.7 The deleterious mutations in the cis-acting element affect its secondary
RNA structure
As discussed earlier (Section 1.6), retroviral cis-acting RNA elements fold
into complex secondary structures comprising of various stem loops (SLs) and
virally-encoded or cellular regulatory proteins bind to these structured elements to
play important functions during retroviral life cycle. This includes the MMTV Rem
binding to RmRE, a RNA structural element with multiple stem loops (Mertz et al.,
2009b). Since we cannot exclude the possibility that the 5’ element can be Remresponsive, we reasoned that if the 5’ cis-acting element is a putative 5’ RmRE, the
detrimental mutations in this region should most likely destabilize the structure of
this region. The 5’ UTR of the MMTV genome and the first 120 nts of Gag have
been shown to be critical for the dimerization and efficient encapsidation of the
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gRNA into newly forming virions (Mustafa et al., 2012; Aktar et al., 2014). The 5’
cis-acting element under investigation overlaps the packaging and dimerization
determinants in the 5’ UTR. Computer modeling and biochemical assays such as
SHAPE (Merino et al., 2005; Mortimer and Weeks 2007; Mortimer and Weeks
2009) have shown this region folds into a stable RNA secondary structure with a
bifurcated stem loop 4 (SL4), the most critical part of this region (Aktar et al., 2014).
SL4 contains both the dimerization initiation site (pal II) as well as a putative Gag
binding site (single-stranded purine, ssPurines) on the two independent loops of the
bifurcated SL4 (Figure 4.1) (Aktar et al., 2014).
Based on this rationale, we compared the Mfold predicted RNA secondary
structures of the affected mutants with the predicted WT RNA secondary structure
(Figure 4.1A & D) to determine the effects of the most drastic mutations (SA5/SQ5
and SA6/SQ6) on the overall structure of this region. As anticipated, SL4 was
observed to lose its bifurcation as well as the internal loop in these mutants (Figures
4.1B/E & C/F), an effect that might contribute to the effect being observed, if the 5’
cis-acting element is a structural RNA element.
4.1.8 Rem-responsiveness of the 5’ cis-acting element
Finally, we used a functional reporter-based assay to determine whether the
5’ UTR of MMTV could be responsive to MMTV Rem. Towards this end, we used
the subgenomic MMTV reporter construct pHMΔeLTRluc (Mertz et al., 2005) to
express region of interest in place of the 3’ RmRE (Figure 3.14). Our results showed
no response to Rem, whereas pHMRluc containing 3’ RmRE was responsive to Rem
that served as a positive control in three different cell lines (Figure 3.15). Later we
learned that a lack of Rem response could be due to an artifact in the design of clones
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Figure 4.1: Predicted RNA secondary structure of the 5’ end MMTV genome
containing WT and mutant sequences using Mfold
The boxed region highlights the SL4 region in the wild type. The blue highlighted
regions show the sequences in SL4 important for RNA dimerization (pal II) and
RNA packaging (ssPurines). The sequences highlighted in pink are the mSD and
Gag ATG, while the yellow highlighted sequences are the 24 nts sequences within
the 5’ cis-acting element that is being investigated. (A) WT (B) SA5/SQ5 mutation
with the entire 24 nts region deleted between the mSD and Gag ATG. (C) SA6/SQ6
has a 12 nts deletion immediately after the mSD. Panels (D-F) show a close-up view
of the SL4 region with the various sequences highlighted as shown in panels A-C.
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since manipulation of the pHMΔeLTRluc construct near the ScaI site has been
observed to affect Rem response to the reporter gene (JP Dudley; Personal
Communication). To preclude this possibility, we are in the process of confirming
these results in the genomic context by deleting the 3’RmRE and simultaneously
inserting a luc gene in HYB MTV molecular clone to test the response of the 5’ cisacting element to Rem.
4.1.9 mRNA elongation is affected by the 5’ cis-acting element
Despite the fact that full-length gRNA expression was clearly affected in
some of the mutants (SQ5, SQ6, SQ10 and SQ11), we could still amplify the MMTV
RNA transcripts in these mutants using primers (OTR671/OTR672) which bound
within R/PBS and to all MMTV mRNAs at the 5’ end of the genome (Figure 3.8C;
Panels III & IV), but not when primers (OFM112/OFM114) were used at the 5’
(upstream of the mSD) and 3’ (U3) ends of the mRNAs (Figure 3.8D; Panels I & II).
This observation suggested a disruption in elongation of transcription.

Such a

scenario has been reported in the case of HIV-1 where elongation of the transcripts is
ensured by the binding of the virally-encoded Tat protein to TAR element present in
the 5’ UTR (Brady and Kashanchi, 2005). But to date, no such mechanism has been
found in MMTV. Since Rem-like proteins from HIV-1 (Rev) and HTLV-1 (Rex)
have been shown to interact with MMTV RmRE (Mertz et al., 2009a), we wondered
whether HIV-1 Tat could bind to the 5’ cis-acting element and trans-activate reporter
gene expression from the MMTV subgenomic constructs tested earlier for Remresponsiveness. Nevertheless, no Tat responsiveness to the 5’ cis-acting element was
observed in our reporter gene assays using three different cell lines (Figures 3.15).
This result rules out that Tat could function as a possible binding factor, unless the
design of the vector is compromised (as discussed earlier). At the same time, it also
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leaves open the possibility that other proteins (either viral or cellular) may be
involved in this process.
Our observation that only a 12 bps deletion was able to severely compromise
transcription in the SA6/SQ6 mutants also suggests that a transcription factor binding
site was disrupted. In support of this assertion, the ZASC1 cellular transcription
factor which belongs to the zinc finger family has been shown to bind to a DNA
binding sites in the U3 region of the 5’ LTR of MLV and HIV-1 to regulate
transcription (Bruce et al., 2010 & 2013). ZASC1 binds to nearly three identical
sites (a 12 bps DNA element) in the MLV LTR promoter to activate gene expression
by interaction and stabilization of the preinitiation complex components with
promoter in mouse and human cells lines (Bruce et al., 2010). On the other hand, in
HIV-1, four possible ZASC1 binding sites have been shown, but the two almost
palindromic sites downstream of the TATA box are more important for viral gene
expression.

Furthermore, in contrast to MLV’s core promoter transcriptional

initiation, ZASC1 in HIV-1 primarily effects transcriptional elongation by a TARindependent recruitment of TAT on HIV-1 core promoter in both tissue culture and
primary T-cell lines (Bruce et al., 2013). It will be interesting to determine if a
protein similar to ZASC1 may be involved in the transcriptional defect being
observed in MMTV.
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4.1.10 The cis-acting element contains binding sites for transcription factors
belonging to the zinc finger family of proteins
To determine what possible known factor(s) could bind to this 27 nt region,
we conducted a preliminary search to look for transcription factors that may bind this
region since the major defect observed was on the transcription of full length gRNA
in the nucleus. Towards this end, use of the online transcription factor prediction tool
MatInspector and PROMO allowed us to locate possible factors that may recognize
the tested region. The MatInspector software locates matches on the query DNA
sequence by utilizing a large library of matrix accounts for transcription factor
binding sites (Cartharius et al., 2005). The PROMO tool constructs weight matrices
from known binding sites extracted from TRANSFAC database that is then used for
the identification of potential binding sites in query sequence (Farré et al., 2003). We
used the WT 27 nt sequence (GTAGGTTACGGTGAGCCATTGGAAATG,
including the bolded mSD and Gag ATG), for the prediction of transcription factor
binding sites in both tools.

Interestingly, these tools predicted several possible

transcription factors that belong to the zinc finger protein family. Specifically,
MatInspector predicted the zinc finger transcription factor OVO homolog-like 1
(Ovol1). Ovol1 belongs to the conserved Ovo gene family that encodes for zinc
finger transcription factors controlling differentiation of a number of tissues in
multicellular organisms, including C. elegans, drosophila, and mice (Li et al., 2005).
Knockout of Ovol1 in mouse has shown severe defects in several tissues, including
testis, skin, kidney and the urogenital tract (Dai et al., 1998). A number of genetic
and biochemical studies have shown its function as a transcriptional regulator. In
mouse, Ovol1 was shown to act downstream of the Wnt–β-catenin–lymphoid
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enhancer factor/T cell factor signaling pathway (Li et al., 2002), a pathway of
relevance to MMTV biology. In another study, Ovol1 was shown as a downstream
target of the TGF-β/BMP7–Smad4 signaling pathway, a growth-inhibitory pathway
in keratinocytes (Nair et al., 2006).
The PROMO tool, on the other hand, predicted a total of 55 possible
transcription factor binding sites to the 27 nt sequence and 7 possible transcription
factors binding within the first 12 nt sequence (deleted in SA6/SQ6 mutant; Figure
3.2). The PROMO-predicted factors with highest similarity index were Zic1 and
Zic2, both of which act as transcriptional activators of the zinc finger protein family
(reviewed in Mizugishi et al., 2001). Zic genes perform crucial functions in neural
development and axial skeletal patterning in the vertebrate embryo. Zic proteins also
function as Gli co-factors in Hedgehog signaling (Cai et al., 2008). Zic2, which is a
regulator of CNS, has been shown to regulate the posttranscriptional modification of
viral genes for activation and their role during viral transition from latency to lytic
cycle in Kaposi’s sarcoma-associated herpes virus (KSHV) (Lyu et al., 2017).
4.1.11 The cis-acting element contains a mirror repeat that could potentially be
involved in the regulation of MMTV gene expression
Careful analysis of the sequences mutated in the 24 nt region revealed the
presence of an imperfect repeat (Figures 4.2A). The repeat sequence was in the
reverse orientation on the same strand, unlike the well-known inverted repeat regions
found as binding sites for transcription factors that are found in the reverse
orientation on the opposite strand (Figure 4.2B). Therefore, it is called a “mirror
repeat” and not a "palindrome". Due to the presence of the inverted repeats on the
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Figure 4.2: Illustration of the mirror repeat observed in the 27 nt cis-acting region of
MMTV
(A) The two mirror repeats were found in between the mSD (GT) and the Gag ATG
(both highlighted in red) on the same strand with three nucleotides in between
(TGA). The orientation of the repeats is shown by the arrows. The letter in blue
shows the one nucleotide that is not consistent with the repeat, making it a partial
repeat. (B) Illustration of a palindrome versus a mirror repeat. (C) Formation of a
hairpin, and (D) a cruciform (a double hairpin structure) from an inverted repeat
palindromic sequence. Figures B, C, and D taken from Nelson and Cox’s Lehninger
Principles of Biochemistry, 5th Edition, 2008).
opposite strand, palindromes can self-fold into hairpins or cruciform (double hairpin)
structures (Figure 4.2C and D). The mirror repeats, on the other hand, do not have
self-complementary sequences within the same strand and therefore cannot form
hairpins or cruciform structures (Nelson and Cox, 2008). Instead, mirror repeats
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have been shown to be part of a special type of triple DNA helix formation called HDNA which is found in polypyrimidine or polypurine rich sequences (Mirkin and
Frank., 1994). Such sequences have been shown to be involved in transcriptional
regulation of genes, and oligonucleotides that have the potential to form these triple
helices are being exploited as potential gene-based drugs that can inhibit both
cellular as well as viral gene expression, as has been shown for c-myc and HIV-1
(reviewed in Dyke, 2013). In one proposed model of their action, such sequences
upstream of genes can recruit proteins that can interfere with the function of either
specific or general transcription factors (reviewed in Dyke, 2013). Thus, such a
sequence upstream of MMTV genes may also be involved in the regulation of
MMTV gene expression.
4.2 Conclusions
Based on the results presented in this study, we propose that the 5’ end of the
MMTV genome contains a cis-acting element found downstream of the LTR in the
5’ untranslated region that is critical for MMTV gene transcription. More than
likely, this element serves as a binding site for a putative viral or cellular
transcription factor residing between the mSD and Gag start codon that regulates
transcription. However, we cannot exclude that it could be part of a larger 5’ RmRE
RNA structural element as well. Further studies are needed to clarify the nature of
this element and identify the factor(s) that may bind there to regulate MMTV gene
expression.
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4.3 Future Directions
Some of the immediate experiments that can be done to elucidate the
mechanism of action of this element include:
1. Rem-responsiveness of WT and Mutant Clones in the Absence of 3’ RmRE.
We would also like to re-test the Rem responsiveness of our cis-acting element in
the absence of the 3’ RmRE in the genomic context since there is some question
about the functionality of the vector that was used in our luciferase reporter assay
(Figure 3.14). This should help clarify the mechanism of action of this cis-acting
element that clearly has a drastic effect on the expression of MMTV gRNAs, and
subsequently the expression of all viral spliced mRNAs, including Env, a singlyspliced mRNA that has been shown to be independent of Rem/RmRE for its
expression (Müllner et al., 2008).

Therefore, the 3’ RmRE in our current

genomic constructs will be deleted with a simultaneous insertion of the Renilla
Luciferase gene.

These constructs will be tested in transient transfections to

determine the effect of the 5’ end mutations on the reporter gene expression in
the presence and absence of Rem. Rescue of RLUC activity in the absence of the
3’ RmRE, but the presence of the 5’ cis-acting element should reveal that the 5’
cis-acting element is indeed Rem-responsive.

Thus, this experiment should

clearly establish whether the 5’ element is a 5’ RmRE or not, irrespective of
whether additionally it contains a transcription factor binding site.

2. Test of the 5’ cis-acting element as a transcription factor binding site.
Finally, we would like to initiate studies to determine whether the 5’ cis-acting
element can serve as a transcription factor binding site/enhancer. This will be
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accomplished in several ways by conducting both RNA-binding, mass
spectrometry, and functional assays to determine whether a viral or cellular factor
is needed for transcriptional activation. This will include RNA and chromatin
immunoprecipitation (ChIP) analysis on cells transfected with the WT construct to
pull out proteins that bind to the 5’ region using antibodies against Ovo-1 and
other potential candidate proteins that may bind that region. We will also follow
up these observations by conducting reporter-based studies to determine the
potential of this region to activate/enhance transcription of the reporter gene.

3. Effect of 5’ End Mutations on the Efficiency of Kozak Sequences:

Our

expression studies using WT and mutant MMTV clones for stable expression in
Jurkat T cells and transient expression in HEK293T revealed the disruption in
translation of Gag and Env proteins in some of the mutants. This translational
effect could partially be an outcome of disruption in the consensus Kozak
sequences due to mutations in the region exactly upstream of the Gag ATG. To
preclude this possibility, we have constructed MMTV subgenomic vectors by
fusing our WT and mutant sequences in-frame to the start codon of the Luciferase
reporter gene in pGL3C vector. These constructs will be tested in transient
transfections in HEK293T cells along with the WT construct to determine the
effect of these mutations on the translational efficiency of the reporter gene.
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